VEEVA SYSTEMS INC, 10-K filed on 3/20/2026
Annual Report
v3.26.1
Cover Page - USD ($)
$ in Billions
 12 Months Ended
Jan. 31, 2026
Mar. 17, 2026
Jul. 31, 2025
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Jan. 31, 2026    
Document Transition Report false    
Entity File Number 001-36121    
Entity Registrant Name Veeva Systems Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 20-8235463    
Entity Address, Address Line One 4280 Hacienda Drive    
Entity Address, City or Town Pleasanton    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 94588    
City Area Code 925    
Local Phone Number 452-6500    
Title of 12(b) Security Class A Common Stock,par value $0.00001 per share    
Trading Symbol VEEV    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 42.6
Entity Common Stock, Shares Outstanding   163,330,933  
Documents Incorporated by Reference
Portions of the registrant’s Proxy Statement for the 2026 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this Form 10-K to the extent stated herein. The proxy statement will be filed by the registrant with the Securities and Exchange Commission within 120 days after the end of the registrant’s fiscal year ended January 31, 2026.
    
Amendment Flag false    
Document Fiscal Year Focus 2026    
Document Fiscal Period Focus FY    
Entity Central Index Key 0001393052    
Current Fiscal Year End Date --01-31    
v3.26.1
Audit Information
 12 Months Ended
Jan. 31, 2026
Audit Information [Abstract]  
Auditor Name KPMG LLP
Auditor Location San Francisco, CA
Auditor Firm ID 185
v3.26.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Current assets:    
Cash and cash equivalents $ 1,421,233 $ 1,118,785
Short-term investments 5,139,581 4,031,442
Accounts receivable, net of allowance for credit losses of $256 and $57, respectively 1,259,737 1,016,356
Unbilled accounts receivable 50,609 40,761
Prepaid expenses and other current assets 126,470 101,458
Total current assets 7,997,630 6,308,802
Property and equipment, net 70,261 55,912
Deferred costs, net 29,961 26,383
Lease right-of-use assets 75,626 63,863
Goodwill 439,877 439,877
Intangible assets, net 30,314 44,460
Deferred income taxes 273,417 343,919
Other long-term assets 62,257 56,540
Total assets 8,979,343 7,339,756
Current liabilities:    
Accounts payable 37,644 30,447
Accrued compensation and benefits 45,857 39,429
Accrued expenses and other current liabilities 45,885 35,557
Income tax payable 6,698 9,024
Deferred revenue 1,488,819 1,273,978
Lease liabilities 12,153 9,969
Total current liabilities 1,637,056 1,398,404
Deferred income taxes 558 587
Long-term lease liabilities 83,706 65,806
Other long-term liabilities 43,271 42,586
Total liabilities 1,764,591 1,507,383
Commitments and contingencies (note 13)
Stockholders’ equity:    
Common stock 2 2
Additional paid-in capital 2,843,089 2,386,192
Accumulated other comprehensive income (loss) 8,160 (8,416)
Retained earnings 4,363,501 3,454,595
Total stockholders’ equity 7,214,752 5,832,373
Total liabilities and stockholders’ equity $ 8,979,343 $ 7,339,756
v3.26.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 256 $ 57
Common stock, par value (in usd per share) $ 0.00001 $ 0.00001
Common stock, shares authorized (in shares) 800,000,000 800,000,000
Common stock, shares issued (in shares) 163,778,271 162,583,789
Common stock, shares outstanding (in shares) 163,778,271 162,583,789
v3.26.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Revenues:      
Total revenues $ 3,195,311 $ 2,746,619 $ 2,363,673
Cost of revenues:      
Total cost of revenues [1] 782,019 699,636 677,291
Gross profit 2,413,292 2,046,983 1,686,382
Operating expenses:      
Research and development [1] 767,386 693,078 629,031
Sales and marketing [1] 428,798 396,726 381,472
General and administrative [1] 300,739 265,744 246,545
Total operating expenses [1] 1,496,923 1,355,548 1,257,048
Operating income 916,369 691,435 429,334
Other income, net 278,139 227,946 158,689
Income before income taxes 1,194,508 919,381 588,023
Income tax provision 285,602 205,243 62,318
Net income $ 908,906 $ 714,138 $ 525,705
Net income per share:      
Basic (in usd per share) $ 5.55 $ 4.41 $ 3.27
Diluted (in usd per share) $ 5.44 $ 4.32 $ 3.22
Weighted Average Number of Shares Outstanding, Diluted [Abstract]      
Basic (in shares) 163,667 161,879 160,532
Diluted (in shares) 166,995 165,232 163,486
Other comprehensive income:      
Net change in unrealized gain on available-for-sale investments $ 17,362 $ 4,094 $ 22,038
Net change in cumulative foreign currency translation loss (786) (1,873) (1,546)
Comprehensive income 925,482 716,359 546,197
Subscription      
Revenues:      
Total revenues 2,684,194 2,284,659 1,901,593
Cost of revenues:      
Total cost of revenues [1] 362,888 323,070 290,577
Professional services and other      
Revenues:      
Total revenues 511,117 461,960 462,080
Cost of revenues:      
Total cost of revenues [1] $ 419,131 $ 376,566 $ 386,714
[1]
(1) Includes stock-based compensation as follows:
Cost of subscription$7,342 $6,591 $6,483 
Cost of professional services and other57,376 51,377 53,237 
Research and development204,893 185,901 172,876 
Sales and marketing97,355 90,178 90,865 
General and administrative105,737 103,303 70,272 
Total stock-based compensation$472,703 $437,350 $393,733 
v3.26.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Total stock-based compensation $ 472,703 $ 437,350 $ 393,733
Cost of subscription      
Total stock-based compensation 7,342 6,591 6,483
Cost of professional services and other      
Total stock-based compensation 57,376 51,377 53,237
Research and development      
Total stock-based compensation 204,893 185,901 172,876
Sales and marketing      
Total stock-based compensation 97,355 90,178 90,865
General and administrative      
Total stock-based compensation $ 105,737 $ 103,303 $ 70,272
v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive (loss) income
Beginning balance (in shares) at Jan. 31, 2023   158,244,607      
Beginning balance at Jan. 31, 2023 $ 3,716,252 $ 2 $ 1,532,627 $ 2,214,752 $ (31,129)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   2,277,533      
Issuance of common stock upon exercise of stock options 62,687   62,687    
Issuance of common stock upon vesting of restricted stock units (in shares)   1,150,059      
Shares withheld related to net share settlement (in shares)   (412,027)      
Shares withheld related to net share settlement (79,825)   (79,825)    
Stock-based compensation expense 399,513   399,513    
Other comprehensive income (loss) 20,492       20,492
Net income 525,705     525,705  
Ending balance (in shares) at Jan. 31, 2024   161,260,172      
Ending balance at Jan. 31, 2024 4,644,824 $ 2 1,915,002 2,740,457 (10,637)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares)   673,079      
Issuance of common stock upon exercise of stock options 105,538   105,538    
Issuance of common stock upon vesting of restricted stock units (in shares)   1,030,545      
Shares withheld related to net share settlement (in shares)   (380,007)      
Shares withheld related to net share settlement (79,116)   (79,116)    
Stock-based compensation expense 444,768   444,768    
Other comprehensive income (loss) 2,221       2,221
Net income $ 714,138     714,138  
Ending balance (in shares) at Jan. 31, 2025 162,583,789 162,583,789      
Ending balance at Jan. 31, 2025 $ 5,832,373 $ 2 2,386,192 3,454,595 (8,416)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options (in shares) 1,374,104 1,374,104      
Issuance of common stock upon exercise of stock options $ 253,863   253,863    
Issuance of common stock upon vesting of restricted stock units (in shares)   988,578      
Shares withheld related to net share settlement (in shares)   (366,465)      
Shares withheld related to net share settlement (93,562)   (93,562)    
Stock-based compensation expense 476,538   476,538    
Other comprehensive income (loss) 16,576       16,576
Net income 908,906     908,906  
Repurchase and retirement of common stock (in shares)   (801,735)      
Repurchase and retirement of common stock $ (179,942)   (179,942)    
Ending balance (in shares) at Jan. 31, 2026 163,778,271 163,778,271      
Ending balance at Jan. 31, 2026 $ 7,214,752 $ 2 $ 2,843,089 $ 4,363,501 $ 8,160
v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Cash flows from operating activities      
Net income $ 908,906 $ 714,138 $ 525,705
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 37,972 39,383 32,628
Reduction of lease right-of-use assets 12,499 11,547 11,691
Accretion of discount on short-term investments (9,693) (24,443) (26,515)
Stock-based compensation 472,703 437,350 393,733
Amortization of deferred costs 16,423 15,528 18,177
Deferred income taxes 65,094 (112,273) (105,374)
Other, net 3,259 1,201 471
Changes in operating assets and liabilities:      
Accounts receivable (244,704) (164,572) (149,810)
Unbilled accounts receivable (9,848) (4,396) 45,809
Deferred costs (20,001) (17,995) (10,268)
Prepaid expenses and other current and long-term assets (33,825) (17,453) 414
Accounts payable 6,080 (1,961) (10,230)
Accrued expenses and other current liabilities 2,982 (1,414) (4,249)
Income tax payable (2,326) (2,838) 6,916
Deferred revenue 213,056 227,838 188,164
Lease liabilities (5,822) (9,835) (6,879)
Other long-term liabilities 2,470 246 956
Net cash provided by operating activities 1,415,225 1,090,051 911,339
Cash flows from investing activities      
Purchases of short-term investments (3,133,080) (2,581,968) (2,697,968)
Maturities and sales of short-term investments 2,057,849 1,902,349 1,647,813
Long-term assets (29,131) (20,519) (26,196)
Net cash used in investing activities (1,104,362) (700,138) (1,076,351)
Cash flows from financing activities      
Proceeds from exercise of common stock options 253,863 105,538 62,687
Repurchases of common stock (169,949) 0 0
Taxes paid related to net share settlement of equity awards (93,247) (79,423) (78,875)
Net cash (used in) provided by financing activities (9,333) 26,115 (16,188)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 919 (1,735) (1,780)
Net change in cash, cash equivalents, and restricted cash 302,449 414,293 (182,980)
Cash, cash equivalents, and restricted cash at beginning of period 1,120,963 706,670 889,650
Cash, cash equivalents, and restricted cash at end of period 1,423,412 1,120,963 706,670
Cash, cash equivalents, and restricted cash at end of period:      
Cash and cash equivalents 1,421,233 1,118,785 703,487
Restricted cash included in other long-term assets 2,179 2,178 3,183
Total cash, cash equivalents, and restricted cash at end of period 1,423,412 1,120,963 706,670
Supplemental disclosures of other cash flow information:      
Cash paid for income taxes, net of refunds 229,965 322,048 134,473
Excess tax benefits from employee stock plans $ 25,273 $ 8,932 $ 71,049
v3.26.1
Summary of Business and Significant Accounting Policies
 12 Months Ended
Jan. 31, 2026
Accounting Policies [Abstract]  
Summary of Business and Significant Accounting Policies Summary of Business and Significant Accounting Policies
Description of Business
Veeva is the leading provider of industry cloud solutions for the global life sciences industry. Our offerings span cloud software, data, and business consulting and are designed to meet the unique needs of our customers and their most strategic business functions—from research and development (“R&D”) through commercialization. Our solutions help life sciences companies develop and bring products to market faster and more efficiently, market and sell more effectively, and maintain compliance with government regulations. Our Commercial Solutions help life sciences companies achieve better, more intelligent engagement with healthcare professionals and healthcare organizations across multiple communication channels, and plan and execute more effective media and marketing campaigns. Our R&D and Quality Solutions for the clinical, regulatory, quality, and safety functions help life sciences companies streamline their end-to-end product development and quality and manufacturing processes to increase operational efficiency and maintain regulatory compliance throughout the product life cycle. Our solutions for clinical research sites enable regulatory documents and trial information to be managed in a modern cloud solution that is intended to accelerate the clinical research process for the life sciences industry overall. Our fiscal year end is January 31.
Principles of Consolidation and Basis of Presentation
These consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding annual financial reporting and include the accounts of our wholly-owned subsidiaries after elimination of intercompany accounts and transactions.
Use of Estimates
The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the consolidated financial statements and the notes thereto. These estimates are based on information available as of the date of the consolidated financial statements. On a regular basis, management evaluates these estimates and assumptions. Items subject to such estimates and assumptions include, but are not limited to:
•the standalone selling price for each distinct performance obligation included in customer contracts with multiple performance obligations;
•the determination of the period of benefit for amortization of deferred costs;
•the realizability of deferred income tax assets;
•the fair value of our stock-based awards.
As future events cannot be determined with precision, actual results could differ significantly from those estimates.
Revenue Recognition
We derive our revenues primarily from subscription services and professional services. Subscription revenues consist of fees from customers accessing our cloud-based software solutions and fees for our data solutions. Professional services and other revenues consist primarily of fees from implementation services, configuration, and managed services in connection with our solutions, as well as services related to our speakers bureau logistics and Veeva Business Consulting offerings. Revenues are recognized when control of these services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those services.
We determine revenue recognition through the following steps:
•Identification of the contract, or contracts, with a customer;
•Identification of the performance obligations in the contract;
•Determination of the transaction price;
•Allocation of the transaction price to the performance obligations in the contract; and
•Recognition of revenue when, or as, we satisfy a performance obligation.
Subscription Revenues
Subscription revenues are recognized ratably over the respective noncancellable subscription term because of the continuous transfer of control to the customer. Our subscription arrangements are considered service contracts, and the customer does not have the right to take possession of the software.
Professional Services and Other Revenues
The majority of our professional services arrangements are billed on a time and materials basis and revenues are recognized over time based on time incurred and contractually agreed upon rates. Certain professional services revenues are billed on a fixed fee basis and revenues are typically recognized over time as the services are delivered based on time incurred. Business consulting services revenues are generally recognized as the services are performed.
Contracts with Multiple Performance Obligations
Some of our contracts with customers contain multiple performance obligations. For these contracts, we account for individual performance obligations separately when they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. We determine the standalone selling prices based on our overall pricing objectives, taking into consideration market conditions and other factors, including other groupings such as customer type and geography.
Deferred Costs
Deferred costs represent sales commissions associated with obtaining a contract with a customer. These costs are deferred and then amortized over a period of benefit that we have determined to be three years. We determined the period of benefit by taking into consideration the expected renewal period of our customer contracts, our technology and other factors. Amortization expense is included in sales and marketing expenses in the accompanying consolidated statements of comprehensive income.
Certain Risks and Concentrations of Credit Risk
Our revenues are derived from subscription services, professional services and other services delivered primarily to the life sciences industry. We operate in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities, and other factors could negatively impact our future operating results.
Our financial instruments that potentially subject us to concentration of credit risk consist primarily of cash and cash equivalents, short-term investments, and accounts receivable. Our cash equivalents and short-term investments are held by established financial institutions. We have established guidelines relative to credit ratings, diversification, and maturities that seek to maintain safety and liquidity. Deposits in these financial institutions may significantly exceed federally insured limits.
We do not require collateral from our customers and generally require payment within 30 days to 60 days of billing.
The following customer exceeded 10% of total accounts receivable as of the dates shown:
January 31,
20262025
Customer 1N/A10.1%
No single customer represented over 10% of our total revenues for any of the years presented.
Cash Equivalents
We consider all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.
Short-term Investments
Our short-term investments are classified as available-for-sale and recorded at estimated fair value. When the fair value of a security is below its amortized cost, the amortized cost will be reduced to its fair value and the resulting loss will be recorded in other income, net in the consolidated statements of comprehensive income, if it is more likely than not that we are required to sell the security before recovery of its amortized cost basis, or we have the intention to sell the security. If neither of these criteria are met, we further assess whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, credit ratings, and any adverse conditions specifically related to the security, among other factors.

Credit related losses are recorded as an allowance on the consolidated balance sheets with a corresponding charge in other income, net in the consolidated statements of comprehensive income.
Non-credit related unrealized losses and unrealized gains are included in accumulated other comprehensive income, a component of stockholders’ equity. Realized gains and losses determined based on the specific identification method are reported in other income, net, in the consolidated statements of comprehensive income. Interest, amortization of premiums, and accretion of discount on all short-term investments are also included as a component of other income, net, in the consolidated statements of comprehensive income.
We may sell our short-term investments at any time for use in current operations or for other purposes, even if they have not yet reached maturity. As a result, we classify our investments, including securities with maturities beyond 12 months, as current assets in the accompanying consolidated balance sheets.
Accounts Receivable and Allowance for Credit Losses
Accounts receivable are recorded at the invoiced amount, net of allowance for credit losses.
Property and Equipment
Property and equipment is stated at cost less accumulated depreciation. Depreciation is calculated on the straight-line method over the estimated useful lives of the assets and commences once the asset is placed in service or ready for its intended use. Land is not depreciated. The estimated useful lives by asset classification are as follows:
Building30 years
Building improvementsRemaining useful life of the building
Equipment and computers3 years
Furniture and fixtures5 years
Land improvements10 years
Leasehold improvementsShorter of remaining life of the lease term or estimated useful life
Leases
We have operating leases for corporate offices.
We recognize lease right-of-use assets and liabilities at the commencement date based on the present value of lease payments over the lease term. We use an estimate of our discount rate based on the information available at the lease commencement date in determining the present value of lease payments, unless the implicit rate is readily determinable. The lease right-of-use assets also include any lease payments made and exclude lease incentives such as tenant improvement allowances. Options to extend or terminate the lease are included in the lease term when it is reasonably certain that we will exercise the extension or termination option.
Our operating leases typically include non-lease components such as common-area maintenance costs. We have elected to exclude non-lease components from lease payments for the purpose of calculating lease right-of-use assets and liabilities and these variable lease payments are expensed as incurred.
Leases with a term of one year or less are not recognized on our consolidated balance sheets; we recognize lease expense for these leases on a straight-line basis over the lease term.
Internal-Use Software
We capitalize certain costs incurred for the development of computer software for internal use. We capitalize these costs during the development of the software project, when it is determined that it is probable that the project will be completed and the software will be used as intended. Costs related to preliminary project activities, post-implementation activities, training, and maintenance are expensed as incurred. Internal-use software is amortized on a straight-line basis over its estimated useful life of three years, and the amortization expense is recorded as a component of cost of subscription. Management evaluates the useful lives of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. Internal-use software is included in other long-term assets on the consolidated balance sheets.
Goodwill and Intangible Assets
Goodwill is evaluated for impairment at least annually or more frequently if circumstances indicate that goodwill may be impaired. A qualitative assessment is performed to determine whether it is more likely than not that the fair value of its reporting unit is less than its carrying amount. If the reporting unit does not pass the qualitative assessment, the carrying amount of the reporting unit, including goodwill, is compared to fair value and goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. Any excess of the carrying value of the goodwill above its fair value is recognized as an impairment loss.
We have one reporting unit and completed our annual impairment test in our fourth quarter of the fiscal year ended January 31, 2026. There were no goodwill impairment charges during any of the periods presented.
Intangible assets associated with purchased intangibles, consisting of existing technology, customer relationships, trade names and trademarks, and data supplier and partner relationships are stated at cost less accumulated amortization and are amortized on a straight-line basis over their estimated remaining economic lives. Amortization expense related to existing technology and data supplier and partner relationships is included in cost of subscription. Amortization expense related to customer relationships and trade names and trademarks is included in sales and marketing expense.
Long-Lived Assets
Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, we first compare undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. There were no impairment charges recognized during any of the periods presented.
Business Combinations
The purchase price in a business combination is assigned to the estimated acquisition date fair values of the tangible and intangible assets acquired and the liabilities assumed with the residual recorded as goodwill. Critical estimates in valuing certain of the intangible assets include, but are not limited to, the net present value of future expected cash flows, future revenue growth, margins, customer retention rates, technology life, royalty rates, expected use of acquired assets, and discount rates.
Stock-based Compensation
We recognize compensation expense for all stock-based awards, including stock options and restricted stock units (“RSUs”), based on the estimate of fair value of the award at the grant date. The fair value of each option award is estimated on the grant date using either a Black-Scholes option-pricing model or a Monte Carlo simulation, to the extent market conditions exist. These models require that at the date of grant we determine the fair value of the underlying common stock, the expected term of the award, the expected volatility of the price of our common stock, risk-free interest rates, and expected dividend yield of our common stock. The fair value of each RSU award is measured based on the closing stock price of our common stock on the date of grant. We account for forfeitures as they occur. Compensation expense for awards with service conditions is recognized on a straight-line basis and for awards with market conditions is recognized on a graded vesting attribution method over the requisite service periods.
Cost of Revenues
Cost of subscription revenues consists of expenses related to our computing infrastructure provided by third parties, including Amazon Web Services and Salesforce, Inc., personnel-related costs associated with hosting our subscription services and providing support, including our data stewards, data acquisition costs, and costs of delivering our data solutions, allocated overhead, amortization expense associated with capitalized internal-use software, and amortization expense associated with purchased intangibles related to our subscription services. Cost of subscription revenues for Veeva CRM and certain of our multichannel customer relationship management applications include fees paid to Salesforce. for our use of the Salesforce platform and the associated hosting infrastructure and data center operations that are provided by Salesforce.
Cost of professional services and other revenues consists primarily of employee-related expenses associated with providing these services, including salaries, benefits and stock-based compensation expense, the cost of third-party subcontractors, travel costs, and allocated overhead.
Advertising Expenses
Advertising expenditures are expensed as incurred and were immaterial for each of the years presented.
Income Taxes
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
We regularly assess the realizability of our deferred tax assets and establish a valuation allowance if it is more likely than not that some or all of our deferred tax assets will not be realized. We evaluate and weigh all available positive and negative evidence such as historic results, future reversals of existing deferred tax liabilities, and projected future taxable income. Generally, more weight is given to objectively verifiable evidence such as the cumulative income in recent years.
We establish liabilities or reduce assets for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining whether the weight of available evidence indicates that it is more likely than not that the position will be sustained upon an audit, including resolution of related appeals or litigation processes, if any. The second step requires us to measure the tax benefit as the largest amount that is more likely than not to be realized upon ultimate settlement. We recognize interest accrued and penalties related to unrecognized tax benefits as a component of income tax provision.
Foreign Currency Exchange
Assets and liabilities of foreign subsidiaries that do not have U.S. dollars as their functional currency are translated into U.S. dollars at the exchange rate on the balance sheet date. Revenues and expenses are translated at the average exchange rate during the period. Equity transactions are translated using historical exchange rates. The resulting translation adjustments are recorded as part of a separate component of the consolidated statements of comprehensive income. Foreign currency transaction gains and losses are included in the consolidated statements of comprehensive income for the period.
Indemnification
Our contracts generally include provisions for indemnifying customers against liabilities if our solutions infringe a third party’s intellectual property rights, and we may also incur liabilities if we breach the security and/or confidentiality obligations in our contracts. We have not incurred any material costs, and we have not accrued any liabilities in the accompanying consolidated financial statements as a result of these obligations.
Loss Contingencies
Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred.
Recently Adopted Accounting Pronouncements
Improvements to Income Tax Disclosures
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires disaggregation of rate reconciliation categories and income taxes paid by jurisdiction, among other amendments. We adopted the new standard during the year ended January 31, 2026 on a prospective basis. See note 7 for more information.
New Accounting Pronouncements Issued and Not Yet Adopted
Targeted Improvements to the Accounting for Internal-Use Software
In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, which modernizes the recognition and capitalization framework for internal-use software development costs in order to reflect current software development practices. The amendments also require Subtopic 360-10 disclosures for all capitalized internal-use software costs. This new standard is effective for our fiscal year beginning on February 1, 2028 and interim periods within that fiscal year and may be applied prospectively, retrospectively, or using a modified transition approach. The Company will early adopt ASU 2025-06 in the fiscal quarter ended April 30, 2026 on a prospective basis. We do not expect the adoption of ASU 2025-06 to have a material impact on our consolidated financial statements.
Disaggregation of Income Statement Expenses
In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosure (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure, in the notes to the financial statements, of additional information about certain costs and expenses for interim and annual reporting periods. This new standard is effective for our fiscal year beginning on
February 1, 2027 and interim periods beginning on February 1, 2028 on a prospective basis. Retrospective application is permitted. We are currently evaluating this ASU to determine its impact on our disclosures.
v3.26.1
Short-Term Investments
 12 Months Ended
Jan. 31, 2026
Investments, Debt and Equity Securities [Abstract]  
Short-Term Investments Short-Term Investments
As of January 31, 2026, short-term investments consisted of the following (in thousands):
Amortized
cost
Gross
unrealized
gains
Gross
unrealized
losses
Estimated
fair
value
Available-for-sale securities:
Certificates of deposit
$27,710 $— $(20)$27,690 
Asset-backed securities260,136 1,912 (131)261,917 
Commercial paper75,367 8 — 75,375 
Corporate notes and bonds3,133,825 21,684 (950)3,154,559 
Foreign government bonds232,271 1,206 (76)233,401 
Municipal securities
37,231 222 — 37,453 
U.S. agency obligations11,699 21 — 11,720 
U.S. treasury securities1,332,382 5,443 (359)1,337,466 
Total available-for-sale securities$5,110,621 $30,496 $(1,536)$5,139,581 
As of January 31, 2025, short-term investments consisted of the following (in thousands):
Amortized
cost
Gross
unrealized
gains
Gross
unrealized
losses
Estimated
fair
value
Available-for-sale securities:
Certificates of deposit
$64,045 $69 $(21)$64,093 
Asset-backed securities526,986 3,257 (232)530,011 
Commercial paper74,468 108 (1)74,575 
Corporate notes and bonds2,202,150 10,588 (5,782)2,206,956 
Foreign government bonds176,684 442 (1,023)176,103 
Municipal securities
67,780 173 (122)67,831 
U.S. agency obligations24,616 94 (1)24,709 
U.S. treasury securities888,968 1,440 (3,244)887,164 
Total available-for-sale securities$4,025,697 $16,171 $(10,426)$4,031,442 
The following table summarizes the estimated fair value of our short-term investments, designated as available-for-sale and classified by the contractual maturity date of the securities as of the dates shown (in thousands):
January 31,
20262025
Due in one year or less$1,025,871 $1,066,558 
Due in greater than one year4,113,710 2,964,884 
Total$5,139,581 $4,031,442 
We have not recorded an allowance for credit losses, as we believe any such losses would be immaterial based on the high credit quality of our investments. It is more likely than not we will hold such securities until maturity or a recovery of the cost basis.
The following table shows the fair values of available-for-sale securities which were in an unrealized loss position, aggregated by investment category, as of January 31, 2026 (in thousands):
Less than 12 months12 months or greater
Fair
value		Gross
unrealized
losses		Fair
value		Gross
unrealized
losses
Certificates of deposit
$27,690 $(20)$— $— 
Asset-backed securities4,091 (80)1,090 (51)
Commercial paper9,960 (1)— — 
Corporate notes and bonds425,464 (950)— — 
Foreign government bonds69,877 (68)8,049 (8)
Municipal securities580 — — — 
U.S. treasury securities140,204 (358)— — 
Total
$677,866 $(1,477)$9,139 $(59)
The following table shows the fair values of available-for-sale securities which were in an unrealized loss position, aggregated by investment category, as of January 31, 2025 (in thousands):
Less than 12 months12 months or greater
Fair
value
Gross
unrealized
losses
Fair ValueGross unrealized losses
Certificates of deposit
$20,095 $(21)$— $— 
Asset-backed securities25,220 (31)44,789 (201)
Commercial paper4,944 (1)— — 
Corporate notes and bonds616,379 (5,569)71,331 (213)
Foreign government bonds76,856 (1,023)— — 
Municipal securities
22,593 (122)— — 
U.S. agency obligations1,865 (1)— — 
U.S. treasury securities439,382 (3,072)173,071 (172)
Total
$1,207,334 $(9,840)$289,191 $(586)
v3.26.1
Deferred Costs
 12 Months Ended
Jan. 31, 2026
Deferred Costs [Abstract]  
Deferred Costs Deferred Costs
Deferred costs, which consist of deferred sales commissions, were $30 million and $26 million as of January 31, 2026 and January 31, 2025, respectively. Amortization expense for deferred costs included in sales and marketing expenses in the consolidated statements of comprehensive income was $16 million, $16 million, and $18 million for the fiscal years ended January 31, 2026, 2025, and 2024, respectively. There have been no impairment losses recorded in relation to the costs capitalized for any period presented.
v3.26.1
Property and Equipment, Net
 12 Months Ended
Jan. 31, 2026
Property, Plant and Equipment [Abstract]  
Property and Equipment, Net Property and Equipment, Net
Property and equipment, net consists of the following as of the dates shown (in thousands):
January 31,
20262025
Land$3,040 $3,040 
Building20,984 20,984 
Land improvements and building improvements22,392 22,392 
Equipment and computers2,293 1,483 
Furniture and fixtures8,060 6,288 
Leasehold improvements45,153 30,186 
Construction in progress2,059 2,992 
Property and equipment, gross
103,981 87,365 
Less accumulated depreciation(33,720)(31,453)
Total property and equipment, net$70,261 $55,912 
Total depreciation expense was immaterial for the fiscal years ended January 31, 2026, 2025, and 2024.
v3.26.1
Goodwill and Intangible Assets
 12 Months Ended
Jan. 31, 2026
Intangible Assets, Net (Excluding Goodwill) [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
Goodwill was $440 million as of both January 31, 2026 and January 31, 2025.
The following table presents the details of intangible assets as of January 31, 2026 (in thousands):
Gross
carrying
amount
Accumulated
amortization
Net
Customer relationships$113,157 $(83,606)$29,551 
Existing technology28,580 (28,170)410 
Other intangibles21,405 (21,052)353 
Total intangible assets$163,142 $(132,828)$30,314 
The following table presents the details of intangible assets as of January 31, 2025 (in thousands):
Gross
carrying
amount		Accumulated
amortization		Net
Customer relationships$113,157 $(73,223)$39,934 
Existing technology28,580 (24,878)3,702 
Other intangibles21,405 (20,581)824 
Total intangible assets$163,142 $(118,682)$44,460 
Amortization expense associated with intangible assets was $14 million, $19 million, and $19 million for the fiscal years ended January 31, 2026, 2025, and 2024, respectively.
As of January 31, 2026, the estimated future amortization expense for intangible assets is as follows (in thousands):
Fiscal YearEstimated
amortization
expense
2027$8,922 
20287,778 
20297,782 
20305,832 
Total$30,314 
 
v3.26.1
Fair Value Measurements
 12 Months Ended
Jan. 31, 2026
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The carrying amounts of accounts receivable, other current assets, accounts payable, and accrued liabilities approximate their fair value due to their short-term nature.
Financial assets and liabilities recorded at fair value in the consolidated financial statements are categorized based upon the level of judgment associated with the inputs used to measure their fair value. Hierarchical levels, which are directly related to the amount of subjectivity associated with the inputs to the valuation of these assets or liabilities, are as follows:
Level 1—Observable inputs, such as quoted prices in active markets for identical assets or liabilities.
Level 2—Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.
Financial assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement requires management to make judgments and considers factors specific to the asset or liability.
The following table presents the fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis as of January 31, 2026 (in thousands):
Level 1
Level 2
Total
Assets
Cash equivalents:
Money market funds$286,504 $— $286,504 
U.S. Treasury securities— 2,611 2,611 
Short-term investments:
Certificates of deposit— 27,690 27,690 
Asset-backed securities— 261,917 261,917 
Commercial paper— 75,375 75,375 
Corporate notes and bonds— 3,154,559 3,154,559 
Foreign government bonds— 233,401 233,401 
Municipal securities— 37,453 37,453 
U.S. agency obligations— 11,720 11,720 
U.S. Treasury securities— 1,337,466 1,337,466 
Foreign currency derivative contracts— 822 822 
Total financial assets$286,504 $5,143,014 $5,429,518 
Liabilities
Foreign currency derivative contracts$— $(3,187)$(3,187)
Total financial liabilities$— $(3,187)$(3,187)
The following table presents the fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis as of January 31, 2025 (in thousands):
Level 1
Level 2
Total
Assets
Cash equivalents:
Money market funds$314,872 $— $314,872 
U.S. Treasury securities— 3,301 3,301 
Short-term investments:
Certificates of deposit— 64,093 64,093 
Asset-backed securities— 530,011 530,011 
Commercial paper— 74,575 74,575 
Corporate notes and bonds— 2,206,956 2,206,956 
Foreign government bonds— 176,103 176,103 
Municipal securities
— 67,831 67,831 
U.S. agency obligations— 24,709 24,709 
U.S. Treasury securities— 887,164 887,164 
Foreign currency derivative contracts— 96 96 
Total financial assets$314,872 $4,034,839 $4,349,711 
Liabilities
Foreign currency derivative contracts$— $(525)$(525)
Total financial liabilities$— $(525)$(525)
We determine the fair value of our security holdings based on pricing from our service providers and market prices from industry-standard independent data providers. The valuation techniques used to measure the fair value of financial instruments having Level 2 inputs were derived from non-binding consensus prices that are corroborated by observable market data or quoted market prices for similar instruments. Such market prices may be quoted prices in active markets for identical assets (Level 1 inputs) or pricing determined using inputs other than quoted prices that are observable either directly or indirectly (Level 2 inputs).
Balance Sheet Hedges
We enter into foreign currency forward contracts in order to hedge our foreign currency exposure. These forward contracts are not designated as hedging instruments under applicable accounting guidance, and therefore, we account for them at fair value with changes in the fair value recorded as a component of other income, net in our consolidated statements of comprehensive income. Cash flows from such forward contracts are classified as operating activities.
For the fiscal year ended January 31, 2026, net realized and unrealized foreign currency losses on hedging were $9 million. The net realized and unrealized foreign currency gains on hedging were not material for the fiscal years ended January 31, 2025 and 2024.
The fair value of our outstanding derivative instruments is summarized below (in thousands): 
January 31,
20262025
Notional amount of foreign currency derivative contracts$354,696 $130,122 
Fair value of foreign currency derivative contracts$356,320 $130,552 
v3.26.1
Income Taxes
 12 Months Ended
Jan. 31, 2026
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The components of income before income taxes by U.S. and foreign jurisdictions were as follows for the periods shown (in thousands):
Fiscal year ended January 31,
202620252024
United States$1,140,527 $890,066 $546,837 
Foreign53,981 29,315 41,186 
Total$1,194,508 $919,381 $588,023 
The majority of our revenues from international sales are invoiced from and collected by our U.S. entity and recognized as a component of income before taxes in the United States as opposed to a foreign jurisdiction.
Provision for income taxes consisted of the following for the periods shown (in thousands):
Fiscal year ended January 31,
202620252024
Current provision:
Federal$160,443 $243,660 $126,174 
State44,196 62,953 29,361 
Foreign15,869 10,903 12,157 
Total current provision220,508 317,516 $167,692 
Deferred provision (benefit)
Federal60,512 (90,035)(87,651)
State8,129 (18,569)(15,739)
Foreign(3,547)(3,669)(1,984)
Total deferred provision (benefit)65,094 (112,273)$(105,374)
Income tax provision$285,602 $205,243 $62,318 
Provision for income taxes differed from the amount computed by applying the federal statutory income tax rate of 21% for the fiscal year ended January 31, 2026 to income before income taxes as a result of the following, prepared in accordance with ASU 2023-09 (in thousands, except percentages):
Fiscal year ended January 31,
2026
Federal tax statutory tax rate$250,845 21.0 %
State and local income taxes, net of federal income tax effect (1)
41,337 3.5 %
Foreign tax effects1,505 0.1 %
Effect of cross-border tax laws
Foreign derived intangible income deduction ("FDII")(13,105)(1.1)%
Other810 0.1 %
Tax credits
R&D credits(22,745)(1.9)%
Other credits(639)(0.1)%
Valuation allowance(655)(0.1)%
Nontaxable or nondeductible items
Nondeductible stock-based compensation32,137 2.7 %
Excess tax benefits on stock-based compensation(16,604)(1.4)%
162(m) limited executive compensation14,510 1.2 %
Other306 — %
Changes in unrecognized tax benefits(1,657)(0.1)%
Other adjustments(443)— %
Income tax provision$285,602 23.9 %
(1) In the fiscal year ended January 31, 2026, state and local income taxes in New Jersey, Pennsylvania, and Massachusetts comprise the majority of the domestic state and local income taxes, net of federal effect category.
The following table presents the required disclosures prior to our adoption of ASU 2023-09. Provision for income taxes differed from the amount computed by applying the federal statutory income tax rate of 21% for each of the fiscal years ended January 31, 2025 and 2024 to income before income taxes as a result of the following (in thousands):
Fiscal year ended January 31,
20252024
Expected provision at statutory tax rate
$193,070 $123,485 
State taxes, net of federal benefit
42,650 12,056 
Tax credits(35,416)(36,333)
Stock-based compensation35,618 (32,054)
Valuation allowance3,726 13,572 
Foreign derived intangible income deduction (“FDII”)
(30,535)(15,489)
Release of income tax reserves
(2,531)(9,201)
Other
(1,339)6,282 
Income tax provision$205,243 $62,318 
The tax effects of temporary differences that give rise to significant portions of our deferred tax assets and liabilities related to the following (in thousands):
January 31,
20262025
Deferred tax assets:
Capitalized expenditures$246,020 $326,533 
Stock-based compensation82,657 68,466 
Tax credit carryforward67,067 64,536 
Lease liabilities25,216 19,737 
Other14,170 14,781 
Gross deferred tax assets435,130 494,053 
Valuation allowance(79,495)(77,056)
Total deferred tax assets355,635 416,997 
Deferred tax liabilities:
Intangible assets(21,945)(23,305)
Lease right-of-use assets(19,988)(16,675)
Other(40,843)(33,685)
Total deferred tax liabilities(82,776)(73,665)
Net deferred tax assets$272,859 $343,332 
In assessing the need for a valuation allowance, the Company considers all positive and negative evidence, including recent financial performance, scheduled reversals of temporary differences and projected future taxable income. Based on a review of such information, management believes that it is possible that some portion of deferred tax assets will not be realized as a future benefit and therefore has recorded a valuation allowance. The valuation allowance at the end of January 31, 2026 was primarily related to certain U.S. state deferred tax assets.
As of January 31, 2026, the net operating loss carryforwards for state income tax purposes were approximately $13 million. The state net operating losses begin to expire in 2031.
As of January 31, 2026, we had $82 million of California research and development tax credits available to offset future taxes which do not expire.
We evaluate tax positions for recognition using a more likely than not recognition threshold, and those tax positions eligible for recognition are measured as the largest amount of tax benefit that is greater than 50% likely of being realized upon the effective settlement with a taxing authority that has full knowledge of all relevant information. We classify unrecognized tax benefits that are not expected to result in payment or receipt of cash within one year as “other non-current liabilities” in the consolidated balance sheets. As of January 31, 2026, the total amount of gross unrecognized tax benefits was $42 million, of which $26 million, if recognized, would favorably impact our effective tax rate. The aggregate changes in our total gross amount of unrecognized tax benefits are summarized as follows for the periods shown (in thousands):
Fiscal year ended January 31,
202620252024
Beginning balance$39,402 $39,737 $30,713 
Increases related to tax positions taken during the prior period584 2 7,385 
Increases related to tax positions taken during the current period4,641 4,242 10,131 
Decreases related to tax positions taken during the prior period(29)(101)(17)
Lapse of statute of limitations(3,051)(4,478)(8,475)
Ending balance$41,547 $39,402 $39,737 
Our policy is to classify interest and penalties associated with unrecognized tax benefits as a component of the provision for income taxes. Accrued interest and penalties included in our liability related to unrecognized tax benefits were $4 million, $3 million, and $2 million as of January 31, 2026, 2025, and 2024, respectively.
We file tax returns in the United States for federal, California, and other states. Fiscal years ended January 31, 2023 and forward remain open to examination for federal income tax, and fiscal years ended January 31, 2018 and forward remain open to examination for California and other states. We file tax returns in multiple foreign
jurisdictions. The fiscal years ended January 31, 2021 and forward remain open to examination in these foreign jurisdictions.
Net cash paid for income taxes, net of refunds, consisted of the following, prepared in accordance with ASU 2023-09 (in thousands):
Fiscal year ended January 31,
2026
Federal$159,500 
State and local
New Jersey15,231 
Pennsylvania11,701 
Other states and localities27,681 
Foreign15,852 
Net cash paid for income taxes$229,965 
v3.26.1
Deferred Revenue, Performance Obligations, and Unbilled Accounts Receivable
 12 Months Ended
Jan. 31, 2026
Revenue Recognition and Deferred Revenue [Abstract]  
Deferred Revenue, Performance Obligations, and Unbilled Accounts Receivable Deferred Revenue, Performance Obligations, and Unbilled Accounts Receivable
Deferred Revenue
Of the beginning deferred revenue balance for the respective periods, we recognized $1,226 million, $1,028 million, and $833 million in revenue for the fiscal years ended January 31, 2026, 2025, and 2024, respectively.
Transaction Price Allocated to the Remaining Performance Obligations
As of January 31, 2026 and January 31, 2025, the amount of the transaction price allocated to remaining performance obligations for noncancellable subscription services contracts greater than one year was not significant with the substantial majority of such allocated transaction price included in deferred revenue and expected to be recognized over the next 12 months.
Unbilled Accounts Receivable
As of January 31, 2026, unbilled accounts receivable consisted of (i) receivables of $40 million primarily for revenue recognized for professional services performed but not yet billed and (ii) contract assets of $11 million primarily related to professional services performed but for which we are not contractually able to invoice until a future period.
As of January 31, 2025, unbilled accounts receivable consisted of (i) receivables of $33 million primarily for revenue recognized for professional services performed but not yet billed and (ii) contract assets of $8 million primarily related to professional services performed but for which we are not contractually able to invoice until a future period.
v3.26.1
Leases
 12 Months Ended
Jan. 31, 2026
Leases [Abstract]  
Leases Leases
We have operating leases for our global offices with various expiration dates, some of which include options to extend the leases for up to five years.
For the fiscal years ended January 31, 2026, 2025, and 2024, our operating lease expense was $17 million, $14 million, and $16 million, respectively.
Supplemental cash flow information related to leases was as follows (in thousands):
Fiscal year ended January 31,
20262025
Cash paid for lease liabilities
$9,545 $12,522 
Lease right-of-use assets obtained in exchange for new lease liabilities
$24,023 $30,866 
Supplemental balance sheet information related to operating leases was as follows:
January 31,
20262025
Weighted average remaining lease term
7.8 years7.7 years
Weighted average discount rate
4.8 %4.6 %
As of January 31, 2026, remaining maturities of lease liabilities are as follows (in thousands):
Fiscal Year
2027$14,851 
202818,538 
202914,984 
203014,053 
203111,293 
Thereafter42,549 
Total lease payments
116,268 
Less imputed interest(20,409)
Total lease liabilities
$95,859 
v3.26.1
Stockholders' Equity
 12 Months Ended
Jan. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Stockholders' Equity Stockholders’ Equity
Common Stock
As of January 31, 2026 and 2025, we had 163,778,271 and 162,583,789 shares of common stock outstanding, respectively.
Voting Rights
The holders of our common stock are entitled to one vote per share.
Stockholders do not have the ability to cumulate votes for the election of directors. Our certificate of incorporation and bylaws provide for a declassified board of directors, with annual election of directors, serving a one-year term.
Dividend Rights
Subject to preferences that may apply to shares of preferred stock outstanding at the time, the holders of outstanding shares of our common stock are entitled to receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends, and only then at the times and in the amounts that our board of directors may determine.
No Preemptive or Similar Rights
Our common stock is not entitled to preemptive rights and is not subject to conversion, redemption, or sinking fund provisions.
Right to Receive Liquidation Distributions
Upon our dissolution, liquidation, or winding-up, the assets legally available for distribution to our stockholders are distributable ratably among the holders of our common stock, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights and payment of liquidation preferences, if any, on any outstanding shares of preferred stock.
Employee Equity Plans
Pursuant to our equity compensation program, the vast majority of our employees are granted RSUs, which typically vest over a one-year period, and stock options, which typically vest over a four-year period.
2013 Equity Incentive Plan
Our board of directors adopted our 2013 Equity Incentive Plan in August 2013, and our stockholders approved it in September 2013. The 2013 Equity Incentive Plan became effective immediately on adoption although no awards were made under it until the date of our IPO on October 15, 2013. Our board of directors approved the amended and restated 2013 Equity Incentive Plan (as amended and restated, 2013 EIP) in March 2022, and our stockholders approved it in June 2022, at which time the amended and restated 2013 EIP took effect.
As of January 31, 2026, the number of shares of our common stock available for issuance under the 2013 EIP was 51,279,704. The number of shares available for issuance under the 2013 EIP automatically increases on the first business day of each of our fiscal years, commencing in 2014, by a number equal to the least of (a) 13.75 million shares, (b) 5% of the shares of our common stock outstanding on the last business day of the prior fiscal year, or (c) the number of shares determined by our board of directors. During our fiscal year ended January 31, 2026, our board of directors determined to add 6,503,351 shares of common stock to the 2013 EIP.
2013 Employee Stock Purchase Plan
Our Employee Stock Purchase Plan (“ESPP”) was adopted by our board of directors in August 2013 and our stockholders approved it in September 2013. The ESPP became effective as of our IPO registration statement on Form S-1, on October 15, 2013. Our ESPP is intended to qualify under Section 423 of the Internal Revenue Code of 1986, as amended (“Code”). The ESPP was approved with a reserve of 4 million shares of common stock for future issuance under various terms provided for in the ESPP. As of January 31, 2026, the number of shares available for issuance under our ESPP was 4,897,856. The number of shares available for issuance under the ESPP automatically increases on the first business day of each of our fiscal years, commencing in 2014, by a number equal to the least of (a) 2.2 million shares, (b) 1% of the shares of our common stock outstanding on the last business day of the prior fiscal year or (c) the number of shares determined by our board of directors. During our fiscal year ended January 31, 2026, our board of directors determined no additional shares were to be made available for issuance under the ESPP.
During active offering periods, our ESPP permits eligible employees to acquire shares of our common stock at 85% of the lower of the fair market value of our common stock on the first day of the applicable offering period or the fair market value of our common stock on the purchase date. Participants may purchase shares of common stock through payroll deductions of up to 15% of their eligible compensation, subject to any plan limitations. The initial offering period for our ESPP commenced on the date of our initial public offering and ended on June 15, 2014. We have not had any open offering periods subsequent to the initial offering period.
Stock Option Activity
The 2013 EIP provides for the issuance of incentive and nonstatutory options to employees, consultants and non-employee directors. Options issued under the 2013 EIP generally are exercisable for periods not to exceed ten years and generally vest over four years, with certain options vesting over five to seven years.
A summary of stock option activity for the fiscal year ended January 31, 2026 is as follows: 
Number
of shares
Weighted
average
exercise
price
Weighted
average
remaining
contractual
term (in years)
Aggregate
intrinsic
value (in millions)
Options outstanding at January 31, 202514,633,921 $177.65 6.8$860 
Options granted2,261,282 $216.48 
Options exercised(1,374,104)$184.75 
Options forfeited/cancelled(386,223)$209.76 
Options outstanding at January 31, 202615,134,876 $181.99 6.3$523 
Options vested and exercisable at January 31, 20266,558,348 $136.89 3.9$496 
Options vested and exercisable at January 31, 2026 and expected to vest thereafter15,134,876 $181.99 6.3$523 
As of January 31, 2026, there was $417 million in unrecognized compensation cost related to unvested stock options granted under the 2013 Equity Incentive Plan. This cost is expected to be recognized over a weighted average period of 2.0 years. The fair value of options vested was $148 million, $152 million, and $114 million for the fiscal years ended January 31, 2026, 2025, and 2024, respectively.
The options granted during the fiscal year ended January 31, 2026 were primarily made in connection with our annual performance review cycle. The weighted average grant-date fair value of options granted was $97.93, $80.69, and $81.17 per option for the fiscal years ended January 31, 2026, 2025, and 2024, respectively. The total intrinsic value of options exercised was approximately $120 million, $45 million, and $353 million for the fiscal years ended January 31, 2026, 2025, and 2024, respectively.
Stock Option Valuation Assumptions
The following table presents the weighted-average assumptions used to estimate the grant date fair value of options granted during the periods presented:

Fiscal year ended January 31,
202620252024
Volatility39%-40%39%-41%39%-41%
Expected term (in years)6.3-7.05.5-7.66.3-7.0
Risk-free interest rate3.68%-4.41%3.46%-4.65%3.34%-4.73%
Dividend yield—%—%—%
During the fiscal year ended January 31, 2025, we granted our Chief Executive Officer (“CEO”) options to purchase an aggregate of 2,650,000 shares of our common stock at an exercise price of $236.90 per share. The stock option carries a market condition and vests through 2030, subject to Mr. Gassner’s continuous service as CEO. As of January 31, 2026, the market condition has been achieved, but no time-based vesting milestone has been reached. The grant date fair value of the stock option of approximately $172 million was calculated using a Monte Carlo simulation model and the following table provides the assumptions used in the simulation:
Volatility39 %
Expected term (in years)7.6
Risk-free interest rate4.18 %
Dividend yield— %
Restricted Stock Units (“RSUs”)
The 2013 EIP provides for the issuance of RSUs to employees. RSUs issued under the 2013 EIP generally vest over a period of one year.
A summary of RSU activity for the fiscal year ended January 31, 2026 is as follows:
Unreleased restricted
stock units
Weighted 
average grant
date fair value
Balance at January 31, 2025880,026 $206.25 
RSUs granted1,065,116 $217.87 
RSUs vested(988,578)$213.67 
RSUs forfeited/cancelled(66,508)$212.68 
Balance at January 31, 2026890,056 $211.42 
As of January 31, 2026, there was a total of $65 million in unrecognized compensation cost related to unvested RSUs. This cost is expected to be recognized over a weighted-average period of approximately 0.6 years. The total fair value of RSUs vested was $253 million, $215 million, and $223 million for the fiscal years ended January 31, 2026, 2025, and 2024, respectively.
The weighted average grant-date fair value of RSUs granted was $217.87, $213.04, and $180.78 per award for the fiscal years ended January 31, 2026, 2025, and 2024, respectively.
Share Repurchase Program
In January 2026, our board of directors authorized a share repurchase program of up to $2 billion of our outstanding shares of common stock. Under the program, we may repurchase shares of common stock from time to time through open market purchases, in privately negotiated transactions, or by other means, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), in accordance with applicable securities laws and other restrictions, including Rule 10b-18 under the Exchange Act. The timing and total amount of any share repurchases depend upon business, economic and market conditions, corporate and regulatory requirements, prevailing stock prices, and other considerations. The share repurchase program has a term of two years, may be suspended or discontinued at any time, and does not obligate us to acquire any amount of common stock. Any repurchased shares of common stock will be retired.
The table below sets forth information regarding repurchase of shares under our share repurchase program (in thousands, except number of shares and per share data):
Fiscal year ended January 31,
2026
Total number of shares repurchased801,735 
Average price paid per share (1)
$224.43 
Amount repurchased (1)
$179,930 
(1) Amounts exclude commissions.
All repurchases were made in open market transactions. As of January 31, 2026, $1.82 billion remained available for future repurchase. Upon retirement, the par value of the common stock repurchased was deducted from the repurchase price of the common stock. Any excess of repurchase price over par value was accounted for entirely as a deduction from additional paid-in capital in the consolidated balance sheets.
v3.26.1
Other Income
 12 Months Ended
Jan. 31, 2026
Other Income and Expenses [Abstract]  
Other Income Other Income
Other income, net, consisted of the following (in thousands):
Fiscal year ended January 31,
202620252024
Foreign currency gain (loss)$1,535 $(3,274)$124 
Accretion on investments8,451 22,622 24,817 
Interest income, net267,219 207,987 133,748 
Miscellaneous income
934 611 — 
Other income, net$278,139 $227,946 $158,689 
v3.26.1
Net Income per Share
 12 Months Ended
Jan. 31, 2026
Earnings Per Share [Abstract]  
Net Income per Share Net Income per Share
Basic net income per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period.
Diluted net income per share is computed by dividing net income by the weighted-average shares outstanding, including potentially dilutive shares of common equivalents outstanding during the period. The dilutive effect of potential shares of common stock is determined using the treasury stock method.
On October 15, 2023, all of our outstanding shares of Class B common stock automatically converted into the same number of shares of Class A common stock pursuant to the terms of our then effective Amended and Restated Certificate of Incorporation. Because shares of Class B common stock were outstanding for a portion of the fiscal year ended January 31, 2024, we have disclosed earnings per share for Class A and Class B common stock for the fiscal year ended January 31, 2024. For the fiscal year ended January 31, 2024, the computation of fully diluted net income per share of Class A common stock assumes the conversion from Class B common stock, while the fully diluted net income per share of Class B common stock does not assume the conversion of those shares.
The following table presents the calculation of basic and diluted net income per share (in thousands, except per share data):
Fiscal year ended January 31,
202620252024
CommonCommonClass AClass B
Numerator:
Net income, basic$908,906 $714,138 $491,747 $33,958 
Reallocation as a result of conversion of Class B to Class A common stock:
Net income, basic— — 33,958 — 
Reallocation of net income to Class B common stock— — — 8,887 
Net income, diluted$908,906 $714,138 $525,705 $42,845 
Denominator:
Basic shares:
Weighted average common shares outstanding, basic
163,667 161,879 150,162 10,370 
Diluted shares:
Weighted average common shares outstanding, basic
163,667 161,879 150,162 10,370 
Conversion of Class B to Class A common stock— — 10,370 — 
Effect of potentially dilutive common shares3,328 3,353 2,954 2,954 
Weighted average common shares outstanding, diluted
166,995 165,232 163,486 13,324 
Net income per share:
Basic
$5.55 $4.41 $3.27 $3.27 
Diluted
$5.44 $4.32 $3.22 $3.22 
Potential common share equivalents excluded because their inclusion would be anti-dilutive are as follows (in thousands):
Fiscal year ended January 31,
202620252024
Options and RSUs
9,549 8,609 6,083 
v3.26.1
Commitments and Contingencies
 12 Months Ended
Jan. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Litigation
On August 13, 2025, Veeva and IQVIA entered into a settlement agreement that resolved all ongoing litigations between Veeva and IQVIA. Prior to that, IQVIA and Veeva had been involved in a series of litigations since 2017, including IQVIA Inc. v. Veeva Systems Inc. (No. 2:17-cv-00177) and IQVIA Inc. v. Veeva Systems Inc. (No. 2:19-cv-15517). Under the terms of the settlement agreement, neither party paid damages to the other party and both parties agreed to dismiss with prejudice all claims and counterclaims currently pending. Accordingly, all claims and
counterclaims were dismissed. We paid approximately $31 million to certain law firms with whom we entered into partial contingency fee arrangements, pursuant to which such law firms were entitled to a success fee if certain non-monetary outcomes are achieved.
From time to time, we may be involved in other legal proceedings and subject to claims incident to the ordinary course of business. Although the results of such legal proceedings and claims cannot be predicted with certainty, we believe we are not currently a party to any other legal proceedings, the outcome of which, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, cash flows, or financial position. Regardless of the outcome, such proceedings can have an adverse impact on us because of defense and settlement costs, diversion of resources, and other factors, and there can be no assurances that favorable outcomes will be obtained.
v3.26.1
Segment Information
 12 Months Ended
Jan. 31, 2026
Segment Reporting [Abstract]  
Segment Information Segment Information
Operating segments are defined as components of an enterprise about which separate financial information is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and assessing performance. We define the term “chief operating decision maker” to be our CEO. Our CEO reviews the financial information presented on a consolidated basis for purposes of allocating resources and evaluating our financial performance. Accordingly, the Company operates as a single operating and reportable segment that is focused on providing industry cloud solutions tailored to the global life sciences industry.
The CEO gauges the effectiveness of investment and resourcing decisions and trends in the overall efficiency of the business over time using multiple measures of performance, including consolidated net income and adjusted operating income, which is an additional measure of our segment profitability. The measure of segment assets is reported on the consolidated balance sheets as total assets.
The following table reconciles the Company’s revenues to consolidated net income and the specific items excluded from cost of revenues and operating expenses to calculate adjusted operating income (in thousands):
Fiscal year ended January 31,
202620252024
Revenues
$3,195,311 $2,746,619 $2,363,673 
Cost of revenues - adjusted:
Cost of subscription revenues352,202 312,169 279,626 
Cost of professional services and other revenues
361,335 324,639 332,927 
Operating expenses - adjusted:
Research and development
562,493 507,092 456,041 
Sales and marketing
321,061 293,105 276,505 
General and administrative
164,375 157,271 176,048 
Operating income - adjusted
1,433,845 1,152,343 842,526 
Other segment items (1)
517,476 460,908 413,192 
Other income, net
278,139 227,946 158,689 
Income tax provision285,602 205,243 62,318 
Consolidated net income
$908,906 $714,138 $525,705 
(1) Other segment items included in consolidated net income consist primarily of stock-based compensation, amortization of purchased intangibles, and litigation settlement-related charges.
Cost of revenues - adjusted, and operating expenses - adjusted, are segment expenses that are regularly provided to the CEO and do not include stock-based compensation, amortization of purchased intangibles, and litigation settlement-related charges, as we exclude them from our internal management reporting processes. We find it useful to exclude these expenses when we assess the appropriate level of various operating expenses and resource allocations when budgeting, planning, and forecasting future periods.
v3.26.1
Information about Geographic Areas and Products
 12 Months Ended
Jan. 31, 2026
Revenue from Contract with Customer [Abstract]  
Information about Geographic Areas and Products Information about Geographic Areas and Products
Information about Geographic Areas
We track and allocate revenues by principal geographic area rather than by individual country, which makes it impractical to disclose revenues for the United States or other specific foreign countries. We measure subscription revenue primarily by the estimated location of the end users in each geographic area for our Commercial Solutions and primarily by the estimated location of usage in each geographic area for our R&D and Quality Solutions. We measure professional services revenue primarily by the location of the resources performing the professional services.
Total revenues by geographic area were as follows for the periods shown below (in thousands):
Fiscal year ended January 31,
202620252024
Revenues by geography
North America$1,903,342 $1,621,697 $1,387,425 
Europe939,630 790,777 662,560 
Asia Pacific280,162 265,735 250,600 
Other international72,177 68,410 63,088 
Total revenues$3,195,311 $2,746,619 $2,363,673 
Long-lived assets by geographic area are as follows as of the periods shown below (in thousands):
January 31,
20262025
Long-lived assets by geography
North America$54,089 $47,144 
Europe11,018 6,778 
Asia Pacific4,239 1,295 
Other international915 695 
Total long-lived assets$70,261 $55,912 
Revenues by Product
We group our revenues into two product areas: Commercial Solutions and R&D and Quality Solutions. Commercial Solutions revenues consist of revenues from our Veeva Commercial Cloud and Veeva Data Cloud solutions. R&D and Quality Solutions revenues consist of revenues from our Veeva Development Cloud and Veeva Quality Cloud solutions.
Total revenues consist of the following (in thousands):
Fiscal year ended January 31,
202620252024
Subscription
Commercial Solutions$1,257,568 $1,104,888 $995,803 
R&D and Quality Solutions1,426,626 1,179,771 905,790 
Total subscription2,684,194 2,284,659 1,901,593 
Professional services and other
Commercial Solutions189,307 185,302 185,981 
R&D and Quality Solutions321,810 276,658 276,099 
Total professional services and other511,117 461,960 462,080 
Total revenues$3,195,311 $2,746,619 $2,363,673 
v3.26.1
401(k) Plan
 12 Months Ended
Jan. 31, 2026
Retirement Benefits [Abstract]  
401(k) Plan 401(k) Plan
We have a qualified defined contribution plan under Section 401(k) of the Internal Revenue Code covering eligible employees, as well as a Registered Retirement Savings Plan (“RRSP”) for eligible employees in Canada. Under the 401(k) plan, we match up to $4,000 per employee per year. Under the RRSP plan, we also match up to $2,000 per employee per year. For the fiscal years ended January 31, 2026, 2025, and 2024, total expense related to these plans was $18 million, $10 million, and $9 million, respectively.
v3.26.1
Subsequent Events
 12 Months Ended
Jan. 31, 2026
Subsequent Events [Abstract]  
Subsequent Events Subsequent Events
On March 10, 2026, we acquired all outstanding stock of Rise Healthcare Tech, Inc. (“Ostro”). Ostro provides an engagement platform for life sciences that gives patients and doctors immediate, compliant answers through an AI-driven chat experience. Veeva completed the acquisition of Ostro for approximately $100 million in cash and long-term equity retention grants. We are currently evaluating the accounting treatment of this acquisition and are in the process of completing the preliminary purchase price allocation of the assets acquired and liabilities assumed.
v3.26.1
Insider Trading Arrangements
 3 Months Ended
Jan. 31, 2026
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Tom Schwenger [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
Name and TitleAction
(Adoption / Termination)		Adoption / Termination Date
Aggregate Number of Shares of Common Stock to be Sold (1)
Expiration Date (2)
Priscilla Hung
Director
Adoption1/9/20261,500 6/30/2026
(1) This number represents the maximum number of shares of common stock that may be sold pursuant to the trading plan. The number of shares actually sold will depend on the satisfaction of certain conditions as set forth in the plan.
(2) In each case, the trading plan may expire on an earlier date if and when all transactions thereunder are completed.
Arrangement Duration 456 days
Priscilla Hung [Member]  
Trading Arrangements, by Individual  
Name Priscilla Hung
Title Director
Rule 10b5-1 Arrangement Adopted true
Adoption Date 1/9/2026
Expiration Date 6/30/2026
Aggregate Available 1,500
v3.26.1
Insider Trading Policies and Procedures
 12 Months Ended
Jan. 31, 2026
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.26.1
Cybersecurity Risk Management and Strategy Disclosure
 12 Months Ended
Jan. 31, 2026
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Information Security Management System
We maintain a comprehensive Information Security Management System (“ISMS”), which is managed by our CISO and is designed to ensure the confidentiality, integrity, and availability of customer data, corporate data (such as intellectual property or source code), employee data, and our systems. Our ISMS is founded on the following industry-leading and regulatory standards:
•ISO 9001:2015 – Quality Management Systems
•ISO/IEC 27001:2022 – Information Security Management
•SOC2 Type II – System and Organization Controls
•SEI Capability Maturity Model Integration (v1.3)
•IT Infrastructure Library (“ITIL”) version 3
•ICH Q9 – Quality Risk Management

Our ISMS is certified to ISO/IEC 27001 and incorporates the ISO/IEC 27017 and ISO/IEC 27018 codes of practice for cloud security and privacy.
Critical elements of our ISMS include:
•Operational measures to monitor and respond to data breaches and cyberattacks. We have application, database, network, and resource monitoring in place that are designated to identify vulnerabilities, protect our applications, and alert incident response personnel. Security incidents are addressed by our Security Incident Management Policy, which includes a formal incident response process. We also provide a trust site that displays upcoming maintenance downtimes, data center incidents, and relevant security communications.
•Preventative measures to hinder or limit cyberattacks. We procure, develop, deploy, and maintain preventative solutions and follow preventative practices for our corporate IT and product engineering infrastructures, as well as the production infrastructure that processes our customer data. These solutions
and practices include identity and access management, separation of duties, secure software development, network and data security, and system hardening.
•Vulnerability and penetration testing. We commission annual vulnerability and penetration testing of certain systems by industry-recognized, third-party security specialists. In addition, our software products undergo internal vulnerability testing using automated and manual methods prior to general availability.
•Training. We require role-based security and security awareness training. All employees receive annual training on our Code of Conduct and our Acceptable Use Policy, which establishes our commitment to protecting the confidential and proprietary information of our customers and partners. In addition, all new hires and contractors must undergo information security awareness training. Subsequent security awareness training is required annually for all active employees and contractors. Employees are trained to promptly report security incidents. Employees in certain roles (e.g., customer support representatives, developers, and hiring managers) receive more extensive data and application security training annually.
•Disaster recovery and business continuity. Our solutions are designed to help avoid single points of failure to reduce the chance of business disruption from security breaches, incidents, and other disruptions of systems. We maintain formally documented recovery processes that may be activated in the event of a significant business disruption of our corporate IT infrastructure or the production infrastructure that processes our customer data. We conduct testing, at least annually, to verify the validity of the recovery processes and provide reports on the test results for production infrastructure that processes our customer data to customers via access to a customer portal.
Process for Identifying Material Cybersecurity Incidents
Potentially material cybersecurity incidents are escalated according to our Security Incident Management Policy to a management response team comprising our Chief Information Officer, Chief Financial Officer, Chief Accounting Officer, General Counsel, Chief Privacy Officer, and Associate General Counsel (Corporate). Our Security Incident Management Policy is designed to inform the management response team about, and monitor, the prevention, detection, mitigation, and remediation of cybersecurity incidents. The management response team is responsible for timely determining materiality and overseeing the appropriate reporting of certain cybersecurity incidents.
Cybersecurity risks, including as a result of any previous cybersecurity incidents, have not materially affected and are not reasonably likely to materially affect our business strategy, results of operations, or financial condition. For additional information regarding risks from cybersecurity threats that we face, and regarding our likelihood of being materially affected by risks from cybersecurity threats, please see Item 1A, “Risk Factors”.
Supplier Management Program
Through our Supplier Management Program, we maintain procedures that specify requirements for the assessment of suppliers and contractors who provide services that may impact our product and process quality. These procedures allow us to identify risks from potential cybersecurity incidents associated with our use of products and services from these suppliers and ensure that there is an appropriate level of oversight of our vendors’ quality systems. We perform initial audits and then periodic, risk-based audits on our suppliers to ensure their products and services conform to our established quality standards.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block] Cybersecurity risk management is integrated into our broader risk management framework. We have a security points of contact program, which embeds security experts into product development, services, and IT teams. In addition, a security council, chaired by our CISO, meets monthly to discuss the security program, security incidents, and ongoing program objectives. The council is comprised of senior leaders in product development, operations, security, quality, and services, and helps ensure that security remains a top priority across the enterprise.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block] The Cybersecurity Committee of our board of directors exercises oversight over our cybersecurity and privacy programs and controls for our products and our internal-use information technology. The Cybersecurity Committee is chaired by a director with cybersecurity expertise and board and executive experience at large technology companies. The Cybersecurity Committee receives reports from management on a regular basis on a range of topics, including the current cybersecurity landscape and emerging threats, the status of ongoing cybersecurity initiatives, incident reports from cybersecurity and privacy events, data privacy policies and procedures, and compliance with regulatory requirements and industry standards.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] The Cybersecurity Committee of our board of directors exercises oversight over our cybersecurity and privacy programs and controls for our products and our internal-use information technology. The Cybersecurity Committee is chaired by a director with cybersecurity expertise and board and executive experience at large technology companies. The Cybersecurity Committee receives reports from management on a regular basis on a range of topics, including the current cybersecurity landscape and emerging threats, the status of ongoing cybersecurity initiatives, incident reports from cybersecurity and privacy events, data privacy policies and procedures, and compliance with regulatory requirements and industry standards.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] The Cybersecurity Committee receives reports from management on a regular basis on a range of topics, including the current cybersecurity landscape and emerging threats, the status of ongoing cybersecurity initiatives, incident reports from cybersecurity and privacy events, data privacy policies and procedures, and compliance with regulatory requirements and industry standards.
Cybersecurity Risk Role of Management [Text Block]
Our day-to-day cybersecurity and technology risk management efforts, including oversight of our information security management system, are led by our Chief Information Officer (“CIO”), a member of our executive leadership team with over three decades of experience in the field, whose cybersecurity experience includes serving in executive roles at other companies leading security, operations, audit, and compliance teams. Our Chief Information Security Officer (“CISO”), who has over two decades of experience in cybersecurity, including over five years at Veeva, reports to the CIO and oversees our security team. Our CISO’s cybersecurity experience includes serving as a security architect and Director of Security Engineering at Veeva, and overseeing security, automation, and performance testing for other technology companies.
Cybersecurity risk management is integrated into our broader risk management framework. We have a security points of contact program, which embeds security experts into product development, services, and IT teams. In addition, a security council, chaired by our CISO, meets monthly to discuss the security program, security incidents, and ongoing program objectives. The council is comprised of senior leaders in product development, operations, security, quality, and services, and helps ensure that security remains a top priority across the enterprise.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Our day-to-day cybersecurity and technology risk management efforts, including oversight of our information security management system, are led by our Chief Information Officer (“CIO”), a member of our executive leadership team with over three decades of experience in the field, whose cybersecurity experience includes serving in executive roles at other companies leading security, operations, audit, and compliance teams. Our Chief Information Security Officer (“CISO”), who has over two decades of experience in cybersecurity, including over five years at Veeva, reports to the CIO and oversees our security team. Our CISO’s cybersecurity experience includes serving as a security architect and Director of Security Engineering at Veeva, and overseeing security, automation, and performance testing for other technology companies.
Cybersecurity risk management is integrated into our broader risk management framework. We have a security points of contact program, which embeds security experts into product development, services, and IT teams. In addition, a security council, chaired by our CISO, meets monthly to discuss the security program, security incidents, and ongoing program objectives. The council is comprised of senior leaders in product development, operations, security, quality, and services, and helps ensure that security remains a top priority across the enterprise.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Our Chief Information Security Officer (“CISO”), who has over two decades of experience in cybersecurity, including over five years at Veeva, reports to the CIO and oversees our security team. Our CISO’s cybersecurity experience includes serving as a security architect and Director of Security Engineering at Veeva, and overseeing security, automation, and performance testing for other technology companies.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] We have a security points of contact program, which embeds security experts into product development, services, and IT teams. In addition, a security council, chaired by our CISO, meets monthly to discuss the security program, security incidents, and ongoing program objectives. The council is comprised of senior leaders in product development, operations, security, quality, and services, and helps ensure that security remains a top priority across the enterprise.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.26.1
Summary of Business and Significant Accounting Policies (Policies)
 12 Months Ended
Jan. 31, 2026
Accounting Policies [Abstract]  
Description of Business
Description of Business
Veeva is the leading provider of industry cloud solutions for the global life sciences industry. Our offerings span cloud software, data, and business consulting and are designed to meet the unique needs of our customers and their most strategic business functions—from research and development (“R&D”) through commercialization. Our solutions help life sciences companies develop and bring products to market faster and more efficiently, market and sell more effectively, and maintain compliance with government regulations. Our Commercial Solutions help life sciences companies achieve better, more intelligent engagement with healthcare professionals and healthcare organizations across multiple communication channels, and plan and execute more effective media and marketing campaigns. Our R&D and Quality Solutions for the clinical, regulatory, quality, and safety functions help life sciences companies streamline their end-to-end product development and quality and manufacturing processes to increase operational efficiency and maintain regulatory compliance throughout the product life cycle. Our solutions for clinical research sites enable regulatory documents and trial information to be managed in a modern cloud solution that is intended to accelerate the clinical research process for the life sciences industry overall. Our fiscal year end is January 31.
Principles of Consolidation and Basis of Presentation
Principles of Consolidation and Basis of Presentation
These consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding annual financial reporting and include the accounts of our wholly-owned subsidiaries after elimination of intercompany accounts and transactions.
Use of Estimates
Use of Estimates
The preparation of consolidated financial statements in conformity with GAAP requires us to make estimates, judgments and assumptions that affect the consolidated financial statements and the notes thereto. These estimates are based on information available as of the date of the consolidated financial statements. On a regular basis, management evaluates these estimates and assumptions. Items subject to such estimates and assumptions include, but are not limited to:
•the standalone selling price for each distinct performance obligation included in customer contracts with multiple performance obligations;
•the determination of the period of benefit for amortization of deferred costs;
•the realizability of deferred income tax assets;
•the fair value of our stock-based awards.
As future events cannot be determined with precision, actual results could differ significantly from those estimates.
Revenue Recognition
Revenue Recognition
We derive our revenues primarily from subscription services and professional services. Subscription revenues consist of fees from customers accessing our cloud-based software solutions and fees for our data solutions. Professional services and other revenues consist primarily of fees from implementation services, configuration, and managed services in connection with our solutions, as well as services related to our speakers bureau logistics and Veeva Business Consulting offerings. Revenues are recognized when control of these services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those services.
We determine revenue recognition through the following steps:
•Identification of the contract, or contracts, with a customer;
•Identification of the performance obligations in the contract;
•Determination of the transaction price;
•Allocation of the transaction price to the performance obligations in the contract; and
•Recognition of revenue when, or as, we satisfy a performance obligation.
Subscription Revenues
Subscription revenues are recognized ratably over the respective noncancellable subscription term because of the continuous transfer of control to the customer. Our subscription arrangements are considered service contracts, and the customer does not have the right to take possession of the software.
Professional Services and Other Revenues
The majority of our professional services arrangements are billed on a time and materials basis and revenues are recognized over time based on time incurred and contractually agreed upon rates. Certain professional services revenues are billed on a fixed fee basis and revenues are typically recognized over time as the services are delivered based on time incurred. Business consulting services revenues are generally recognized as the services are performed.
Contracts with Multiple Performance Obligations
Some of our contracts with customers contain multiple performance obligations. For these contracts, we account for individual performance obligations separately when they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. We determine the standalone selling prices based on our overall pricing objectives, taking into consideration market conditions and other factors, including other groupings such as customer type and geography.
Deferred Costs
Deferred Costs
Deferred costs represent sales commissions associated with obtaining a contract with a customer. These costs are deferred and then amortized over a period of benefit that we have determined to be three years. We determined the period of benefit by taking into consideration the expected renewal period of our customer contracts, our technology and other factors. Amortization expense is included in sales and marketing expenses in the accompanying consolidated statements of comprehensive income.
Certain Risks and Concentrations of Credit Risk
Certain Risks and Concentrations of Credit Risk
Our revenues are derived from subscription services, professional services and other services delivered primarily to the life sciences industry. We operate in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities, and other factors could negatively impact our future operating results.
Our financial instruments that potentially subject us to concentration of credit risk consist primarily of cash and cash equivalents, short-term investments, and accounts receivable. Our cash equivalents and short-term investments are held by established financial institutions. We have established guidelines relative to credit ratings, diversification, and maturities that seek to maintain safety and liquidity. Deposits in these financial institutions may significantly exceed federally insured limits.
We do not require collateral from our customers and generally require payment within 30 days to 60 days of billing.
Cash Equivalents
Cash Equivalents
We consider all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents.
Short-term Investments
Short-term Investments
Our short-term investments are classified as available-for-sale and recorded at estimated fair value. When the fair value of a security is below its amortized cost, the amortized cost will be reduced to its fair value and the resulting loss will be recorded in other income, net in the consolidated statements of comprehensive income, if it is more likely than not that we are required to sell the security before recovery of its amortized cost basis, or we have the intention to sell the security. If neither of these criteria are met, we further assess whether the decline in fair value below amortized cost is due to credit or non-credit related factors. In making this assessment, we consider the extent to which fair value is less than amortized cost, credit ratings, and any adverse conditions specifically related to the security, among other factors.

Credit related losses are recorded as an allowance on the consolidated balance sheets with a corresponding charge in other income, net in the consolidated statements of comprehensive income.
Non-credit related unrealized losses and unrealized gains are included in accumulated other comprehensive income, a component of stockholders’ equity. Realized gains and losses determined based on the specific identification method are reported in other income, net, in the consolidated statements of comprehensive income. Interest, amortization of premiums, and accretion of discount on all short-term investments are also included as a component of other income, net, in the consolidated statements of comprehensive income.
We may sell our short-term investments at any time for use in current operations or for other purposes, even if they have not yet reached maturity. As a result, we classify our investments, including securities with maturities beyond 12 months, as current assets in the accompanying consolidated balance sheets.
Accounts Receivable and Allowance for Credit Losses
Accounts Receivable and Allowance for Credit Losses
Accounts receivable are recorded at the invoiced amount, net of allowance for credit losses.
Property and Equipment
Property and Equipment
Property and equipment is stated at cost less accumulated depreciation. Depreciation is calculated on the straight-line method over the estimated useful lives of the assets and commences once the asset is placed in service or ready for its intended use. Land is not depreciated.
Leases
Leases
We have operating leases for corporate offices.
We recognize lease right-of-use assets and liabilities at the commencement date based on the present value of lease payments over the lease term. We use an estimate of our discount rate based on the information available at the lease commencement date in determining the present value of lease payments, unless the implicit rate is readily determinable. The lease right-of-use assets also include any lease payments made and exclude lease incentives such as tenant improvement allowances. Options to extend or terminate the lease are included in the lease term when it is reasonably certain that we will exercise the extension or termination option.
Our operating leases typically include non-lease components such as common-area maintenance costs. We have elected to exclude non-lease components from lease payments for the purpose of calculating lease right-of-use assets and liabilities and these variable lease payments are expensed as incurred.
Leases with a term of one year or less are not recognized on our consolidated balance sheets; we recognize lease expense for these leases on a straight-line basis over the lease term.
Internal-Use Software
Internal-Use Software
We capitalize certain costs incurred for the development of computer software for internal use. We capitalize these costs during the development of the software project, when it is determined that it is probable that the project will be completed and the software will be used as intended. Costs related to preliminary project activities, post-implementation activities, training, and maintenance are expensed as incurred. Internal-use software is amortized on a straight-line basis over its estimated useful life of three years, and the amortization expense is recorded as a component of cost of subscription. Management evaluates the useful lives of these assets on an annual basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. Internal-use software is included in other long-term assets on the consolidated balance sheets.
Goodwill and Intangible Assets
Goodwill and Intangible Assets
Goodwill is evaluated for impairment at least annually or more frequently if circumstances indicate that goodwill may be impaired. A qualitative assessment is performed to determine whether it is more likely than not that the fair value of its reporting unit is less than its carrying amount. If the reporting unit does not pass the qualitative assessment, the carrying amount of the reporting unit, including goodwill, is compared to fair value and goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. Any excess of the carrying value of the goodwill above its fair value is recognized as an impairment loss.
We have one reporting unit and completed our annual impairment test in our fourth quarter of the fiscal year ended January 31, 2026. There were no goodwill impairment charges during any of the periods presented.
Intangible assets associated with purchased intangibles, consisting of existing technology, customer relationships, trade names and trademarks, and data supplier and partner relationships are stated at cost less accumulated amortization and are amortized on a straight-line basis over their estimated remaining economic lives. Amortization expense related to existing technology and data supplier and partner relationships is included in cost of subscription. Amortization expense related to customer relationships and trade names and trademarks is included in sales and marketing expense.
Long-Lived Assets
Long-Lived Assets
Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. If circumstances require a long-lived asset or asset group be tested for possible impairment, we first compare undiscounted cash flows expected to be generated by that asset or asset group to its carrying value. If the carrying value of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment is recognized to the extent that the carrying value exceeds its fair value. There were no impairment charges recognized during any of the periods presented.
Business Combinations
Business Combinations
The purchase price in a business combination is assigned to the estimated acquisition date fair values of the tangible and intangible assets acquired and the liabilities assumed with the residual recorded as goodwill. Critical estimates in valuing certain of the intangible assets include, but are not limited to, the net present value of future expected cash flows, future revenue growth, margins, customer retention rates, technology life, royalty rates, expected use of acquired assets, and discount rates.
Stock-based Compensation
Stock-based Compensation
We recognize compensation expense for all stock-based awards, including stock options and restricted stock units (“RSUs”), based on the estimate of fair value of the award at the grant date. The fair value of each option award is estimated on the grant date using either a Black-Scholes option-pricing model or a Monte Carlo simulation, to the extent market conditions exist. These models require that at the date of grant we determine the fair value of the underlying common stock, the expected term of the award, the expected volatility of the price of our common stock, risk-free interest rates, and expected dividend yield of our common stock. The fair value of each RSU award is measured based on the closing stock price of our common stock on the date of grant. We account for forfeitures as they occur. Compensation expense for awards with service conditions is recognized on a straight-line basis and for awards with market conditions is recognized on a graded vesting attribution method over the requisite service periods.
Cost of Revenues
Cost of Revenues
Cost of subscription revenues consists of expenses related to our computing infrastructure provided by third parties, including Amazon Web Services and Salesforce, Inc., personnel-related costs associated with hosting our subscription services and providing support, including our data stewards, data acquisition costs, and costs of delivering our data solutions, allocated overhead, amortization expense associated with capitalized internal-use software, and amortization expense associated with purchased intangibles related to our subscription services. Cost of subscription revenues for Veeva CRM and certain of our multichannel customer relationship management applications include fees paid to Salesforce. for our use of the Salesforce platform and the associated hosting infrastructure and data center operations that are provided by Salesforce.
Cost of professional services and other revenues consists primarily of employee-related expenses associated with providing these services, including salaries, benefits and stock-based compensation expense, the cost of third-party subcontractors, travel costs, and allocated overhead.
Advertising Expenses
Advertising Expenses
Advertising expenditures are expensed as incurred and were immaterial for each of the years presented.
Income Taxes
Income Taxes
Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.
We regularly assess the realizability of our deferred tax assets and establish a valuation allowance if it is more likely than not that some or all of our deferred tax assets will not be realized. We evaluate and weigh all available positive and negative evidence such as historic results, future reversals of existing deferred tax liabilities, and projected future taxable income. Generally, more weight is given to objectively verifiable evidence such as the cumulative income in recent years.
We establish liabilities or reduce assets for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining whether the weight of available evidence indicates that it is more likely than not that the position will be sustained upon an audit, including resolution of related appeals or litigation processes, if any. The second step requires us to measure the tax benefit as the largest amount that is more likely than not to be realized upon ultimate settlement. We recognize interest accrued and penalties related to unrecognized tax benefits as a component of income tax provision.
Foreign Currency Exchange
Foreign Currency Exchange
Assets and liabilities of foreign subsidiaries that do not have U.S. dollars as their functional currency are translated into U.S. dollars at the exchange rate on the balance sheet date. Revenues and expenses are translated at the average exchange rate during the period. Equity transactions are translated using historical exchange rates. The resulting translation adjustments are recorded as part of a separate component of the consolidated statements of comprehensive income. Foreign currency transaction gains and losses are included in the consolidated statements of comprehensive income for the period.
Indemnification
Indemnification
Our contracts generally include provisions for indemnifying customers against liabilities if our solutions infringe a third party’s intellectual property rights, and we may also incur liabilities if we breach the security and/or confidentiality obligations in our contracts. We have not incurred any material costs, and we have not accrued any liabilities in the accompanying consolidated financial statements as a result of these obligations.
Loss Contingencies
Loss Contingencies
Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties, and other sources are recorded when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Legal costs incurred in connection with loss contingencies are expensed as incurred.
Recently Adopted Accounting Pronouncements and New Accounting Pronouncements Issued and Not yet Adopted
Recently Adopted Accounting Pronouncements
Improvements to Income Tax Disclosures
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires disaggregation of rate reconciliation categories and income taxes paid by jurisdiction, among other amendments. We adopted the new standard during the year ended January 31, 2026 on a prospective basis. See note 7 for more information.
New Accounting Pronouncements Issued and Not Yet Adopted
Targeted Improvements to the Accounting for Internal-Use Software
In September 2025, the FASB issued ASU 2025-06, Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, which modernizes the recognition and capitalization framework for internal-use software development costs in order to reflect current software development practices. The amendments also require Subtopic 360-10 disclosures for all capitalized internal-use software costs. This new standard is effective for our fiscal year beginning on February 1, 2028 and interim periods within that fiscal year and may be applied prospectively, retrospectively, or using a modified transition approach. The Company will early adopt ASU 2025-06 in the fiscal quarter ended April 30, 2026 on a prospective basis. We do not expect the adoption of ASU 2025-06 to have a material impact on our consolidated financial statements.
Disaggregation of Income Statement Expenses
In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosure (Subtopic 220-40): Disaggregation of Income Statement Expenses, which requires disclosure, in the notes to the financial statements, of additional information about certain costs and expenses for interim and annual reporting periods. This new standard is effective for our fiscal year beginning on
February 1, 2027 and interim periods beginning on February 1, 2028 on a prospective basis. Retrospective application is permitted. We are currently evaluating this ASU to determine its impact on our disclosures.
Net Income per Share
Basic net income per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period.
Diluted net income per share is computed by dividing net income by the weighted-average shares outstanding, including potentially dilutive shares of common equivalents outstanding during the period. The dilutive effect of potential shares of common stock is determined using the treasury stock method.
v3.26.1
Summary of Business and Significant Accounting Policies (Tables)
 12 Months Ended
Jan. 31, 2026
Accounting Policies [Abstract]  
Schedule of Certain Risks and Concentrations of Credit Risk
The following customer exceeded 10% of total accounts receivable as of the dates shown:
January 31,
20262025
Customer 1N/A10.1%
Schedule of Estimated Useful Lives of Property and Equipment The estimated useful lives by asset classification are as follows:
Building30 years
Building improvementsRemaining useful life of the building
Equipment and computers3 years
Furniture and fixtures5 years
Land improvements10 years
Leasehold improvementsShorter of remaining life of the lease term or estimated useful life
Property and equipment, net consists of the following as of the dates shown (in thousands):
January 31,
20262025
Land$3,040 $3,040 
Building20,984 20,984 
Land improvements and building improvements22,392 22,392 
Equipment and computers2,293 1,483 
Furniture and fixtures8,060 6,288 
Leasehold improvements45,153 30,186 
Construction in progress2,059 2,992 
Property and equipment, gross
103,981 87,365 
Less accumulated depreciation(33,720)(31,453)
Total property and equipment, net$70,261 $55,912 
v3.26.1
Short-Term Investments (Tables)
 12 Months Ended
Jan. 31, 2026
Investments, Debt and Equity Securities [Abstract]  
Schedule of Short-Term Investments
As of January 31, 2026, short-term investments consisted of the following (in thousands):
Amortized
cost
Gross
unrealized
gains
Gross
unrealized
losses
Estimated
fair
value
Available-for-sale securities:
Certificates of deposit
$27,710 $— $(20)$27,690 
Asset-backed securities260,136 1,912 (131)261,917 
Commercial paper75,367 8 — 75,375 
Corporate notes and bonds3,133,825 21,684 (950)3,154,559 
Foreign government bonds232,271 1,206 (76)233,401 
Municipal securities
37,231 222 — 37,453 
U.S. agency obligations11,699 21 — 11,720 
U.S. treasury securities1,332,382 5,443 (359)1,337,466 
Total available-for-sale securities$5,110,621 $30,496 $(1,536)$5,139,581 
As of January 31, 2025, short-term investments consisted of the following (in thousands):
Amortized
cost
Gross
unrealized
gains
Gross
unrealized
losses
Estimated
fair
value
Available-for-sale securities:
Certificates of deposit
$64,045 $69 $(21)$64,093 
Asset-backed securities526,986 3,257 (232)530,011 
Commercial paper74,468 108 (1)74,575 
Corporate notes and bonds2,202,150 10,588 (5,782)2,206,956 
Foreign government bonds176,684 442 (1,023)176,103 
Municipal securities
67,780 173 (122)67,831 
U.S. agency obligations24,616 94 (1)24,709 
U.S. treasury securities888,968 1,440 (3,244)887,164 
Total available-for-sale securities$4,025,697 $16,171 $(10,426)$4,031,442 
Schedule of Estimated Fair Value of Short-Term Investments, Designated as Available-for-Sale and Classified by Contractual Maturity
The following table summarizes the estimated fair value of our short-term investments, designated as available-for-sale and classified by the contractual maturity date of the securities as of the dates shown (in thousands):
January 31,
20262025
Due in one year or less$1,025,871 $1,066,558 
Due in greater than one year4,113,710 2,964,884 
Total$5,139,581 $4,031,442 
Schedule of Fair Values and Gross Unrealized Loss Position of Available-for-Sale Securities Aggregated by Investment Category
The following table shows the fair values of available-for-sale securities which were in an unrealized loss position, aggregated by investment category, as of January 31, 2026 (in thousands):
Less than 12 months12 months or greater
Fair
value		Gross
unrealized
losses		Fair
value		Gross
unrealized
losses
Certificates of deposit
$27,690 $(20)$— $— 
Asset-backed securities4,091 (80)1,090 (51)
Commercial paper9,960 (1)— — 
Corporate notes and bonds425,464 (950)— — 
Foreign government bonds69,877 (68)8,049 (8)
Municipal securities580 — — — 
U.S. treasury securities140,204 (358)— — 
Total
$677,866 $(1,477)$9,139 $(59)
The following table shows the fair values of available-for-sale securities which were in an unrealized loss position, aggregated by investment category, as of January 31, 2025 (in thousands):
Less than 12 months12 months or greater
Fair
value
Gross
unrealized
losses
Fair ValueGross unrealized losses
Certificates of deposit
$20,095 $(21)$— $— 
Asset-backed securities25,220 (31)44,789 (201)
Commercial paper4,944 (1)— — 
Corporate notes and bonds616,379 (5,569)71,331 (213)
Foreign government bonds76,856 (1,023)— — 
Municipal securities
22,593 (122)— — 
U.S. agency obligations1,865 (1)— — 
U.S. treasury securities439,382 (3,072)173,071 (172)
Total
$1,207,334 $(9,840)$289,191 $(586)
v3.26.1
Property and Equipment, Net (Tables)
 12 Months Ended
Jan. 31, 2026
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment, Net The estimated useful lives by asset classification are as follows:
Building30 years
Building improvementsRemaining useful life of the building
Equipment and computers3 years
Furniture and fixtures5 years
Land improvements10 years
Leasehold improvementsShorter of remaining life of the lease term or estimated useful life
Property and equipment, net consists of the following as of the dates shown (in thousands):
January 31,
20262025
Land$3,040 $3,040 
Building20,984 20,984 
Land improvements and building improvements22,392 22,392 
Equipment and computers2,293 1,483 
Furniture and fixtures8,060 6,288 
Leasehold improvements45,153 30,186 
Construction in progress2,059 2,992 
Property and equipment, gross
103,981 87,365 
Less accumulated depreciation(33,720)(31,453)
Total property and equipment, net$70,261 $55,912 
v3.26.1
Goodwill and Intangible Assets (Tables)
 12 Months Ended
Jan. 31, 2026
Intangible Assets, Net (Excluding Goodwill) [Abstract]  
Schedule of Details of Intangible Assets
The following table presents the details of intangible assets as of January 31, 2026 (in thousands):
Gross
carrying
amount
Accumulated
amortization
Net
Customer relationships$113,157 $(83,606)$29,551 
Existing technology28,580 (28,170)410 
Other intangibles21,405 (21,052)353 
Total intangible assets$163,142 $(132,828)$30,314 
The following table presents the details of intangible assets as of January 31, 2025 (in thousands):
Gross
carrying
amount		Accumulated
amortization		Net
Customer relationships$113,157 $(73,223)$39,934 
Existing technology28,580 (24,878)3,702 
Other intangibles21,405 (20,581)824 
Total intangible assets$163,142 $(118,682)$44,460 
Schedule of Estimated Future Amortization Expense
As of January 31, 2026, the estimated future amortization expense for intangible assets is as follows (in thousands):
Fiscal YearEstimated
amortization
expense
2027$8,922 
20287,778 
20297,782 
20305,832 
Total$30,314 
 
v3.26.1
Fair Value Measurements (Tables)
 12 Months Ended
Jan. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of Fair Value Hierarchy for Financial Assets and Liabilities Measured at Fair Value on Recurring Basis
The following table presents the fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis as of January 31, 2026 (in thousands):
Level 1
Level 2
Total
Assets
Cash equivalents:
Money market funds$286,504 $— $286,504 
U.S. Treasury securities— 2,611 2,611 
Short-term investments:
Certificates of deposit— 27,690 27,690 
Asset-backed securities— 261,917 261,917 
Commercial paper— 75,375 75,375 
Corporate notes and bonds— 3,154,559 3,154,559 
Foreign government bonds— 233,401 233,401 
Municipal securities— 37,453 37,453 
U.S. agency obligations— 11,720 11,720 
U.S. Treasury securities— 1,337,466 1,337,466 
Foreign currency derivative contracts— 822 822 
Total financial assets$286,504 $5,143,014 $5,429,518 
Liabilities
Foreign currency derivative contracts$— $(3,187)$(3,187)
Total financial liabilities$— $(3,187)$(3,187)
The following table presents the fair value hierarchy for financial assets and liabilities measured at fair value on a recurring basis as of January 31, 2025 (in thousands):
Level 1
Level 2
Total
Assets
Cash equivalents:
Money market funds$314,872 $— $314,872 
U.S. Treasury securities— 3,301 3,301 
Short-term investments:
Certificates of deposit— 64,093 64,093 
Asset-backed securities— 530,011 530,011 
Commercial paper— 74,575 74,575 
Corporate notes and bonds— 2,206,956 2,206,956 
Foreign government bonds— 176,103 176,103 
Municipal securities
— 67,831 67,831 
U.S. agency obligations— 24,709 24,709 
U.S. Treasury securities— 887,164 887,164 
Foreign currency derivative contracts— 96 96 
Total financial assets$314,872 $4,034,839 $4,349,711 
Liabilities
Foreign currency derivative contracts$— $(525)$(525)
Total financial liabilities$— $(525)$(525)
Schedule of Fair Value of Outstanding Derivative Instruments
The fair value of our outstanding derivative instruments is summarized below (in thousands): 
January 31,
20262025
Notional amount of foreign currency derivative contracts$354,696 $130,122 
Fair value of foreign currency derivative contracts$356,320 $130,552 
v3.26.1
Income Taxes (Tables)
 12 Months Ended
Jan. 31, 2026
Income Tax Disclosure [Abstract]  
Schedule of Components of Income before Income Taxes
The components of income before income taxes by U.S. and foreign jurisdictions were as follows for the periods shown (in thousands):
Fiscal year ended January 31,
202620252024
United States$1,140,527 $890,066 $546,837 
Foreign53,981 29,315 41,186 
Total$1,194,508 $919,381 $588,023 
Schedule of Components of Provision for Income Taxes
Provision for income taxes consisted of the following for the periods shown (in thousands):
Fiscal year ended January 31,
202620252024
Current provision:
Federal$160,443 $243,660 $126,174 
State44,196 62,953 29,361 
Foreign15,869 10,903 12,157 
Total current provision220,508 317,516 $167,692 
Deferred provision (benefit)
Federal60,512 (90,035)(87,651)
State8,129 (18,569)(15,739)
Foreign(3,547)(3,669)(1,984)
Total deferred provision (benefit)65,094 (112,273)$(105,374)
Income tax provision$285,602 $205,243 $62,318 
Schedule of Reconciliation of Statutory Federal Income Tax to Effective Tax
Provision for income taxes differed from the amount computed by applying the federal statutory income tax rate of 21% for the fiscal year ended January 31, 2026 to income before income taxes as a result of the following, prepared in accordance with ASU 2023-09 (in thousands, except percentages):
Fiscal year ended January 31,
2026
Federal tax statutory tax rate$250,845 21.0 %
State and local income taxes, net of federal income tax effect (1)
41,337 3.5 %
Foreign tax effects1,505 0.1 %
Effect of cross-border tax laws
Foreign derived intangible income deduction ("FDII")(13,105)(1.1)%
Other810 0.1 %
Tax credits
R&D credits(22,745)(1.9)%
Other credits(639)(0.1)%
Valuation allowance(655)(0.1)%
Nontaxable or nondeductible items
Nondeductible stock-based compensation32,137 2.7 %
Excess tax benefits on stock-based compensation(16,604)(1.4)%
162(m) limited executive compensation14,510 1.2 %
Other306 — %
Changes in unrecognized tax benefits(1,657)(0.1)%
Other adjustments(443)— %
Income tax provision$285,602 23.9 %
(1) In the fiscal year ended January 31, 2026, state and local income taxes in New Jersey, Pennsylvania, and Massachusetts comprise the majority of the domestic state and local income taxes, net of federal effect category.
The following table presents the required disclosures prior to our adoption of ASU 2023-09. Provision for income taxes differed from the amount computed by applying the federal statutory income tax rate of 21% for each of the fiscal years ended January 31, 2025 and 2024 to income before income taxes as a result of the following (in thousands):
Fiscal year ended January 31,
20252024
Expected provision at statutory tax rate
$193,070 $123,485 
State taxes, net of federal benefit
42,650 12,056 
Tax credits(35,416)(36,333)
Stock-based compensation35,618 (32,054)
Valuation allowance3,726 13,572 
Foreign derived intangible income deduction (“FDII”)
(30,535)(15,489)
Release of income tax reserves
(2,531)(9,201)
Other
(1,339)6,282 
Income tax provision$205,243 $62,318 
Schedule of Components of Deferred Tax Assets and Liabilities
The tax effects of temporary differences that give rise to significant portions of our deferred tax assets and liabilities related to the following (in thousands):
January 31,
20262025
Deferred tax assets:
Capitalized expenditures$246,020 $326,533 
Stock-based compensation82,657 68,466 
Tax credit carryforward67,067 64,536 
Lease liabilities25,216 19,737 
Other14,170 14,781 
Gross deferred tax assets435,130 494,053 
Valuation allowance(79,495)(77,056)
Total deferred tax assets355,635 416,997 
Deferred tax liabilities:
Intangible assets(21,945)(23,305)
Lease right-of-use assets(19,988)(16,675)
Other(40,843)(33,685)
Total deferred tax liabilities(82,776)(73,665)
Net deferred tax assets$272,859 $343,332 
Schedule of Changes in Total Gross Amount of Unrecognized Tax Benefits The aggregate changes in our total gross amount of unrecognized tax benefits are summarized as follows for the periods shown (in thousands):
Fiscal year ended January 31,
202620252024
Beginning balance$39,402 $39,737 $30,713 
Increases related to tax positions taken during the prior period584 2 7,385 
Increases related to tax positions taken during the current period4,641 4,242 10,131 
Decreases related to tax positions taken during the prior period(29)(101)(17)
Lapse of statute of limitations(3,051)(4,478)(8,475)
Ending balance$41,547 $39,402 $39,737 
Schedule of Refunds Received for Income Taxes
Net cash paid for income taxes, net of refunds, consisted of the following, prepared in accordance with ASU 2023-09 (in thousands):
Fiscal year ended January 31,
2026
Federal$159,500 
State and local
New Jersey15,231 
Pennsylvania11,701 
Other states and localities27,681 
Foreign15,852 
Net cash paid for income taxes$229,965 
v3.26.1
Leases (Tables)
 12 Months Ended
Jan. 31, 2026
Leases [Abstract]  
Schedule of Supplemental Cash Flow Information Related to Leases
Supplemental cash flow information related to leases was as follows (in thousands):
Fiscal year ended January 31,
20262025
Cash paid for lease liabilities
$9,545 $12,522 
Lease right-of-use assets obtained in exchange for new lease liabilities
$24,023 $30,866 
Schedule of Supplemental Balance Sheet Information Related to Leases
Supplemental balance sheet information related to operating leases was as follows:
January 31,
20262025
Weighted average remaining lease term
7.8 years7.7 years
Weighted average discount rate
4.8 %4.6 %
Schedule of Maturity of Operating Lease Liabilities
As of January 31, 2026, remaining maturities of lease liabilities are as follows (in thousands):
Fiscal Year
2027$14,851 
202818,538 
202914,984 
203014,053 
203111,293 
Thereafter42,549 
Total lease payments
116,268 
Less imputed interest(20,409)
Total lease liabilities
$95,859 
v3.26.1
Stockholders' Equity (Tables)
 12 Months Ended
Jan. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity A summary of stock option activity for the fiscal year ended January 31, 2026 is as follows: 
Number
of shares
Weighted
average
exercise
price
Weighted
average
remaining
contractual
term (in years)
Aggregate
intrinsic
value (in millions)
Options outstanding at January 31, 202514,633,921 $177.65 6.8$860 
Options granted2,261,282 $216.48 
Options exercised(1,374,104)$184.75 
Options forfeited/cancelled(386,223)$209.76 
Options outstanding at January 31, 202615,134,876 $181.99 6.3$523 
Options vested and exercisable at January 31, 20266,558,348 $136.89 3.9$496 
Options vested and exercisable at January 31, 2026 and expected to vest thereafter15,134,876 $181.99 6.3$523 
Schedule of Weighted-Average Assumptions Used to Estimate Grant Date Fair Value of Options Granted
The following table presents the weighted-average assumptions used to estimate the grant date fair value of options granted during the periods presented:

Fiscal year ended January 31,
202620252024
Volatility39%-40%39%-41%39%-41%
Expected term (in years)6.3-7.05.5-7.66.3-7.0
Risk-free interest rate3.68%-4.41%3.46%-4.65%3.34%-4.73%
Dividend yield—%—%—%
As of January 31, 2026, the market condition has been achieved, but no time-based vesting milestone has been reached. The grant date fair value of the stock option of approximately $172 million was calculated using a Monte Carlo simulation model and the following table provides the assumptions used in the simulation:
Volatility39 %
Expected term (in years)7.6
Risk-free interest rate4.18 %
Dividend yield— %
Schedule of Restricted Stock Unit (RSU) Activity
A summary of RSU activity for the fiscal year ended January 31, 2026 is as follows:
Unreleased restricted
stock units
Weighted 
average grant
date fair value
Balance at January 31, 2025880,026 $206.25 
RSUs granted1,065,116 $217.87 
RSUs vested(988,578)$213.67 
RSUs forfeited/cancelled(66,508)$212.68 
Balance at January 31, 2026890,056 $211.42 
Schedule of Repurchase Programs
The table below sets forth information regarding repurchase of shares under our share repurchase program (in thousands, except number of shares and per share data):
Fiscal year ended January 31,
2026
Total number of shares repurchased801,735 
Average price paid per share (1)
$224.43 
Amount repurchased (1)
$179,930 
(1) Amounts exclude commissions.
v3.26.1
Other Income (Tables)
 12 Months Ended
Jan. 31, 2026
Other Income and Expenses [Abstract]  
Schedule of Other Income
Other income, net, consisted of the following (in thousands):
Fiscal year ended January 31,
202620252024
Foreign currency gain (loss)$1,535 $(3,274)$124 
Accretion on investments8,451 22,622 24,817 
Interest income, net267,219 207,987 133,748 
Miscellaneous income
934 611 — 
Other income, net$278,139 $227,946 $158,689 
v3.26.1
Net Income per Share (Tables)
 12 Months Ended
Jan. 31, 2026
Earnings Per Share [Abstract]  
Schedule of Numerators and Denominators of the Basic and Diluted EPS Computations for Common Stock
The following table presents the calculation of basic and diluted net income per share (in thousands, except per share data):
Fiscal year ended January 31,
202620252024
CommonCommonClass AClass B
Numerator:
Net income, basic$908,906 $714,138 $491,747 $33,958 
Reallocation as a result of conversion of Class B to Class A common stock:
Net income, basic— — 33,958 — 
Reallocation of net income to Class B common stock— — — 8,887 
Net income, diluted$908,906 $714,138 $525,705 $42,845 
Denominator:
Basic shares:
Weighted average common shares outstanding, basic
163,667 161,879 150,162 10,370 
Diluted shares:
Weighted average common shares outstanding, basic
163,667 161,879 150,162 10,370 
Conversion of Class B to Class A common stock— — 10,370 — 
Effect of potentially dilutive common shares3,328 3,353 2,954 2,954 
Weighted average common shares outstanding, diluted
166,995 165,232 163,486 13,324 
Net income per share:
Basic
$5.55 $4.41 $3.27 $3.27 
Diluted
$5.44 $4.32 $3.22 $3.22 
Schedule of Potential Common Share Equivalents Excluded where the Inclusion would be Anti-dilutive
Potential common share equivalents excluded because their inclusion would be anti-dilutive are as follows (in thousands):
Fiscal year ended January 31,
202620252024
Options and RSUs
9,549 8,609 6,083 
v3.26.1
Segment Information (Tables)
 12 Months Ended
Jan. 31, 2026
Segment Reporting [Abstract]  
Reconciliation of Operating Profit (Loss) from Segments to Consolidated
The following table reconciles the Company’s revenues to consolidated net income and the specific items excluded from cost of revenues and operating expenses to calculate adjusted operating income (in thousands):
Fiscal year ended January 31,
202620252024
Revenues
$3,195,311 $2,746,619 $2,363,673 
Cost of revenues - adjusted:
Cost of subscription revenues352,202 312,169 279,626 
Cost of professional services and other revenues
361,335 324,639 332,927 
Operating expenses - adjusted:
Research and development
562,493 507,092 456,041 
Sales and marketing
321,061 293,105 276,505 
General and administrative
164,375 157,271 176,048 
Operating income - adjusted
1,433,845 1,152,343 842,526 
Other segment items (1)
517,476 460,908 413,192 
Other income, net
278,139 227,946 158,689 
Income tax provision285,602 205,243 62,318 
Consolidated net income
$908,906 $714,138 $525,705 
(1) Other segment items included in consolidated net income consist primarily of stock-based compensation, amortization of purchased intangibles, and litigation settlement-related charges.
v3.26.1
Information about Geographic Areas and Products (Tables)
 12 Months Ended
Jan. 31, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of Revenues by Geographic Area
Total revenues by geographic area were as follows for the periods shown below (in thousands):
Fiscal year ended January 31,
202620252024
Revenues by geography
North America$1,903,342 $1,621,697 $1,387,425 
Europe939,630 790,777 662,560 
Asia Pacific280,162 265,735 250,600 
Other international72,177 68,410 63,088 
Total revenues$3,195,311 $2,746,619 $2,363,673 
Schedule of Long-Lived Assets by Geographic Area
Long-lived assets by geographic area are as follows as of the periods shown below (in thousands):
January 31,
20262025
Long-lived assets by geography
North America$54,089 $47,144 
Europe11,018 6,778 
Asia Pacific4,239 1,295 
Other international915 695 
Total long-lived assets$70,261 $55,912 
Schedule of Total Revenues
Total revenues consist of the following (in thousands):
Fiscal year ended January 31,
202620252024
Subscription
Commercial Solutions$1,257,568 $1,104,888 $995,803 
R&D and Quality Solutions1,426,626 1,179,771 905,790 
Total subscription2,684,194 2,284,659 1,901,593 
Professional services and other
Commercial Solutions189,307 185,302 185,981 
R&D and Quality Solutions321,810 276,658 276,099 
Total professional services and other511,117 461,960 462,080 
Total revenues$3,195,311 $2,746,619 $2,363,673 
v3.26.1
Summary of Business and Significant Accounting Policies - Additional Information (Detail)
 12 Months Ended
Jan. 31, 2026
USD ($)
reporting_unit
Jan. 31, 2025
USD ($)
Jan. 31, 2024
USD ($)
Concentration Risk [Line Items]      
Amortization period of deferred costs 3 years    
Highly liquid investments maturity 3 months    
Number of reporting units | reporting_unit 1    
Impairment of goodwill $ 0 $ 0 $ 0
Impairment recognized for long-lived assets $ 0 $ 0 $ 0
Software Development      
Concentration Risk [Line Items]      
Finite-lived intangible asset, useful life 3 years    
Minimum      
Concentration Risk [Line Items]      
Customer payment period 30 days    
Maximum      
Concentration Risk [Line Items]      
Customer payment period 60 days    
v3.26.1
Summary of Business and Significant Accounting Policies - Concentrations of Credit Risk (Details)
 12 Months Ended
Jan. 31, 2025
Customer One | Accounts Receivable | Customer Concentration Risk  
Concentration Risk [Line Items]  
Concentration risk, percentage 10.10%
v3.26.1
Summary of Business and Significant Accounting Policies - Estimated Useful Lives (Details)
Jan. 31, 2026
Building  
Property, Plant and Equipment [Line Items]  
Property and equipment, estimated useful life 30 years
Equipment and computers  
Property, Plant and Equipment [Line Items]  
Property and equipment, estimated useful life 3 years
Furniture and fixtures  
Property, Plant and Equipment [Line Items]  
Property and equipment, estimated useful life 5 years
Land Improvements  
Property, Plant and Equipment [Line Items]  
Property and equipment, estimated useful life 10 years
v3.26.1
Short-Term Investments - Schedule of Short-Term Investments (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Debt Securities, Available-for-Sale [Line Items]    
Amortized cost $ 5,110,621 $ 4,025,697
Gross unrealized gains 30,496 16,171
Gross unrealized losses (1,536) (10,426)
Estimated fair value 5,139,581 4,031,442
Certificates of deposit    
Debt Securities, Available-for-Sale [Line Items]    
Amortized cost 27,710 64,045
Gross unrealized gains 0 69
Gross unrealized losses (20) (21)
Estimated fair value 27,690 64,093
Asset-backed securities    
Debt Securities, Available-for-Sale [Line Items]    
Amortized cost 260,136 526,986
Gross unrealized gains 1,912 3,257
Gross unrealized losses (131) (232)
Estimated fair value 261,917 530,011
Commercial paper    
Debt Securities, Available-for-Sale [Line Items]    
Amortized cost 75,367 74,468
Gross unrealized gains 8 108
Gross unrealized losses 0 (1)
Estimated fair value 75,375 74,575
Corporate notes and bonds    
Debt Securities, Available-for-Sale [Line Items]    
Amortized cost 3,133,825 2,202,150
Gross unrealized gains 21,684 10,588
Gross unrealized losses (950) (5,782)
Estimated fair value 3,154,559 2,206,956
Foreign government bonds    
Debt Securities, Available-for-Sale [Line Items]    
Amortized cost 232,271 176,684
Gross unrealized gains 1,206 442
Gross unrealized losses (76) (1,023)
Estimated fair value 233,401 176,103
Municipal securities    
Debt Securities, Available-for-Sale [Line Items]    
Amortized cost 37,231 67,780
Gross unrealized gains 222 173
Gross unrealized losses 0 (122)
Estimated fair value 37,453 67,831
U.S. agency obligations    
Debt Securities, Available-for-Sale [Line Items]    
Amortized cost 11,699 24,616
Gross unrealized gains 21 94
Gross unrealized losses 0 (1)
Estimated fair value 11,720 24,709
U.S. treasury securities    
Debt Securities, Available-for-Sale [Line Items]    
Amortized cost 1,332,382 888,968
Gross unrealized gains 5,443 1,440
Gross unrealized losses (359) (3,244)
Estimated fair value $ 1,337,466 $ 887,164
v3.26.1
Short-Term Investments - Schedule of Estimated Fair Value of Short-Term Investments, Designated as Available-for-Sale and Classified by Contractual Maturity (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Investments, Debt and Equity Securities [Abstract]    
Due in one year or less $ 1,025,871 $ 1,066,558
Due in greater than one year 4,113,710 2,964,884
Total $ 5,139,581 $ 4,031,442
v3.26.1
Short-Term Investments - Schedule of Fair Values and Gross Unrealized Loss Position of Available-for-Sale Securities Aggregated by Investment Category (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Debt Securities, Available-for-Sale [Line Items]    
12 months or less, Fair value $ 677,866 $ 1,207,334
12 months or less, Gross unrealized losses (1,477) (9,840)
Greater than 12 months, Fair value 9,139 289,191
Greater than 12 months, Gross unrealized losses (59) (586)
Certificates of deposit    
Debt Securities, Available-for-Sale [Line Items]    
12 months or less, Fair value 27,690 20,095
12 months or less, Gross unrealized losses (20) (21)
Greater than 12 months, Fair value 0 0
Greater than 12 months, Gross unrealized losses 0 0
Asset-backed securities    
Debt Securities, Available-for-Sale [Line Items]    
12 months or less, Fair value 4,091 25,220
12 months or less, Gross unrealized losses (80) (31)
Greater than 12 months, Fair value 1,090 44,789
Greater than 12 months, Gross unrealized losses (51) (201)
Commercial paper    
Debt Securities, Available-for-Sale [Line Items]    
12 months or less, Fair value 9,960 4,944
12 months or less, Gross unrealized losses (1) (1)
Greater than 12 months, Fair value 0 0
Greater than 12 months, Gross unrealized losses 0 0
Corporate notes and bonds    
Debt Securities, Available-for-Sale [Line Items]    
12 months or less, Fair value 425,464 616,379
12 months or less, Gross unrealized losses (950) (5,569)
Greater than 12 months, Fair value 0 71,331
Greater than 12 months, Gross unrealized losses 0 (213)
Foreign government bonds    
Debt Securities, Available-for-Sale [Line Items]    
12 months or less, Fair value 69,877 76,856
12 months or less, Gross unrealized losses (68) (1,023)
Greater than 12 months, Fair value 8,049 0
Greater than 12 months, Gross unrealized losses (8) 0
Municipal securities    
Debt Securities, Available-for-Sale [Line Items]    
12 months or less, Fair value 580 22,593
12 months or less, Gross unrealized losses 0 (122)
Greater than 12 months, Fair value 0 0
Greater than 12 months, Gross unrealized losses 0 0
U.S. treasury securities    
Debt Securities, Available-for-Sale [Line Items]    
12 months or less, Fair value 140,204 439,382
12 months or less, Gross unrealized losses (358) (3,072)
Greater than 12 months, Fair value 0 173,071
Greater than 12 months, Gross unrealized losses $ 0 (172)
U.S. agency obligations    
Debt Securities, Available-for-Sale [Line Items]    
12 months or less, Fair value   1,865
12 months or less, Gross unrealized losses   (1)
Greater than 12 months, Fair value   0
Greater than 12 months, Gross unrealized losses   $ 0
v3.26.1
Deferred Costs (Details) - USD ($)
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Deferred Costs [Abstract]      
Deferred costs $ 29,961,000 $ 26,383,000  
Amortization of deferred costs 16,000,000 16,000,000 $ 18,000,000
Impairment losses recorded in relation to the costs capitalized $ 0 $ 0 $ 0
v3.26.1
Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 103,981 $ 87,365
Less accumulated depreciation (33,720) (31,453)
Total property and equipment, net 70,261 55,912
Land    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 3,040 3,040
Building    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 20,984 20,984
Land improvements and building improvements    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 22,392 22,392
Equipment and computers    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 2,293 1,483
Furniture and fixtures    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 8,060 6,288
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 45,153 30,186
Construction in progress    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 2,059 $ 2,992
v3.26.1
Goodwill and Intangible Assets - Additional Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Intangible Assets, Net (Excluding Goodwill) [Abstract]      
Goodwill $ 439,877 $ 439,877  
Amortization expense $ 14,000 $ 19,000 $ 19,000
v3.26.1
Goodwill and Intangible Assets - Schedule of Details of Intangible Assets (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Finite-Lived Intangible Assets [Line Items]    
Gross carrying amount $ 163,142 $ 163,142
Accumulated amortization (132,828) (118,682)
Net 30,314 44,460
Customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Gross carrying amount 113,157 113,157
Accumulated amortization (83,606) (73,223)
Net 29,551 39,934
Existing technology    
Finite-Lived Intangible Assets [Line Items]    
Gross carrying amount 28,580 28,580
Accumulated amortization (28,170) (24,878)
Net 410 3,702
Other intangibles    
Finite-Lived Intangible Assets [Line Items]    
Gross carrying amount 21,405 21,405
Accumulated amortization (21,052) (20,581)
Net $ 353 $ 824
v3.26.1
Goodwill and Intangible Assets - Schedule of Estimated Future Amortization Expense (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Intangible Assets, Net (Excluding Goodwill) [Abstract]    
2027 $ 8,922  
2028 7,778  
2029 7,782  
2030 5,832  
Net $ 30,314 $ 44,460
v3.26.1
Fair Value Measurements - Schedule of Fair Value Hierarchy for Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Assets    
Short-term investments $ 5,139,581 $ 4,031,442
Total financial assets 5,429,518 4,349,711
Liabilities    
Total financial liabilities (3,187) (525)
Money market funds    
Assets    
Cash equivalents: 286,504 314,872
U.S. Treasury securities    
Assets    
Cash equivalents: 2,611 3,301
Short-term investments 1,337,466 887,164
Certificates of deposit    
Assets    
Short-term investments 27,690 64,093
Asset-backed securities    
Assets    
Short-term investments 261,917 530,011
Commercial paper    
Assets    
Short-term investments 75,375 74,575
Corporate notes and bonds    
Assets    
Short-term investments 3,154,559 2,206,956
Foreign government bonds    
Assets    
Short-term investments 233,401 176,103
Municipal securities    
Assets    
Short-term investments 37,453 67,831
U.S. agency obligations    
Assets    
Short-term investments 11,720 24,709
Foreign currency derivative contracts    
Assets    
Short-term investments 822 96
Foreign currency derivative contracts    
Liabilities    
Foreign currency derivative contracts (3,187) (525)
Level 1    
Assets    
Total financial assets 286,504 314,872
Liabilities    
Total financial liabilities 0 0
Level 1 | Money market funds    
Assets    
Cash equivalents: 286,504 314,872
Level 1 | U.S. Treasury securities    
Assets    
Cash equivalents: 0 0
Short-term investments 0 0
Level 1 | Certificates of deposit    
Assets    
Short-term investments 0 0
Level 1 | Asset-backed securities    
Assets    
Short-term investments 0 0
Level 1 | Commercial paper    
Assets    
Short-term investments 0 0
Level 1 | Corporate notes and bonds    
Assets    
Short-term investments 0 0
Level 1 | Foreign government bonds    
Assets    
Short-term investments 0 0
Level 1 | Municipal securities    
Assets    
Short-term investments 0 0
Level 1 | U.S. agency obligations    
Assets    
Short-term investments 0 0
Level 1 | Foreign currency derivative contracts    
Assets    
Short-term investments 0 0
Level 1 | Foreign currency derivative contracts    
Liabilities    
Foreign currency derivative contracts 0 0
Level 2    
Assets    
Total financial assets 5,143,014 4,034,839
Liabilities    
Total financial liabilities (3,187) (525)
Level 2 | Money market funds    
Assets    
Cash equivalents: 0 0
Level 2 | U.S. Treasury securities    
Assets    
Cash equivalents: 2,611 3,301
Short-term investments 1,337,466 887,164
Level 2 | Certificates of deposit    
Assets    
Short-term investments 27,690 64,093
Level 2 | Asset-backed securities    
Assets    
Short-term investments 261,917 530,011
Level 2 | Commercial paper    
Assets    
Short-term investments 75,375 74,575
Level 2 | Corporate notes and bonds    
Assets    
Short-term investments 3,154,559 2,206,956
Level 2 | Foreign government bonds    
Assets    
Short-term investments 233,401 176,103
Level 2 | Municipal securities    
Assets    
Short-term investments 37,453 67,831
Level 2 | U.S. agency obligations    
Assets    
Short-term investments 11,720 24,709
Level 2 | Foreign currency derivative contracts    
Assets    
Short-term investments 822 96
Level 2 | Foreign currency derivative contracts    
Liabilities    
Foreign currency derivative contracts $ (3,187) $ (525)
v3.26.1
Fair Value Measurements - Narrative (Details) - USD ($)
$ in Millions
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Fair Value Disclosures [Abstract]      
Realized foreign currency loss on hedges $ 9 $ 0 $ 0
Unrealized foreign currency loss on hedges $ 9 $ 0 $ 0
v3.26.1
Fair Value Measurements - Schedule of Fair Value of Outstanding Derivative Instruments (Details) - Foreign currency derivative contracts - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Derivatives, Fair Value [Line Items]    
Notional amount of foreign currency derivative contracts $ 354,696 $ 130,122
Fair value of foreign currency derivative contracts $ 356,320 $ 130,552
v3.26.1
Income Taxes - Schedule of Components of Income before Income Taxes (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Income Tax Disclosure [Abstract]      
United States $ 1,140,527 $ 890,066 $ 546,837
Foreign 53,981 29,315 41,186
Income before income taxes $ 1,194,508 $ 919,381 $ 588,023
v3.26.1
Income Taxes - Schedule of Components of Provision for Income Taxes (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Current provision:      
Federal $ 160,443 $ 243,660 $ 126,174
State 44,196 62,953 29,361
Foreign 15,869 10,903 12,157
Total current provision 220,508 317,516 167,692
Deferred provision (benefit)      
Federal 60,512 (90,035) (87,651)
State 8,129 (18,569) (15,739)
Foreign (3,547) (3,669) (1,984)
Total deferred provision (benefit) 65,094 (112,273) (105,374)
Income tax provision $ 285,602 $ 205,243 $ 62,318
v3.26.1
Income Taxes - Schedule of Reconciliation of Statutory Federal Income Tax to Effective Tax (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Amount      
Expected provision at statutory tax rate $ 250,845 $ 193,070 $ 123,485
State taxes, net of federal benefit 41,337 42,650 12,056
Foreign tax effects 1,505    
Foreign derived intangible income deduction ("FDII") (13,105) (30,535) (15,489)
Effect of cross-border tax laws, other 810    
R&D credits (22,745)    
Other credits (639)    
Valuation allowance (655) 3,726 13,572
Stock-based compensation 32,137 35,618 (32,054)
Excess tax benefits on stock-based compensation (16,604)    
162(m) limited executive compensation 14,510    
Other 306    
Changes in unrecognized tax benefits (1,657)    
Other adjustments (443)    
Tax credits   (35,416) (36,333)
Release of income tax reserves   (2,531) (9,201)
Other   (1,339) 6,282
Income tax provision $ 285,602 $ 205,243 $ 62,318
Percent      
Federal tax statutory tax rate 21.00% 21.00% 21.00%
State and local income taxes, net of federal income tax effect 3.50%    
Foreign tax effects 0.10%    
Foreign derived intangible income deduction ("FDII") (1.10%)    
Other 0.10%    
R&D credits (1.90%)    
Other credits (0.10%)    
Valuation allowance (0.10%)    
Nondeductible stock-based compensation 2.70%    
Excess tax benefits on stock-based compensation (1.40%)    
162(m) limited executive compensation 1.20%    
Other 0.00%    
Changes in unrecognized tax benefits (0.10%)    
Other adjustments 0.00%    
Income tax provision 23.90%    
v3.26.1
Income Taxes - Schedule of Components of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Deferred tax assets:    
Capitalized expenditures $ 246,020 $ 326,533
Stock-based compensation 82,657 68,466
Tax credit carryforward 67,067 64,536
Lease liabilities 25,216 19,737
Other 14,170 14,781
Gross deferred tax assets 435,130 494,053
Valuation allowance (79,495) (77,056)
Total deferred tax assets 355,635 416,997
Deferred tax liabilities:    
Intangible assets (21,945) (23,305)
Lease right-of-use assets (19,988) (16,675)
Other (40,843) (33,685)
Total deferred tax liabilities (82,776) (73,665)
Net deferred tax assets $ 272,859 $ 343,332
v3.26.1
Income Taxes - Additional Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Jan. 31, 2023
Income Tax Holiday [Line Items]        
Federal tax statutory tax rate 21.00% 21.00% 21.00%  
State net operating loss carryforwards $ 13,000      
Unrecognized tax benefits 41,547 $ 39,402 $ 39,737 $ 30,713
Unrecognized tax benefits that would impact effective tax rate 26,000      
Accrued interest and penalties 4,000 $ 3,000 $ 2,000  
State and Local Jurisdiction | California Franchise Tax Board        
Income Tax Holiday [Line Items]        
Tax credit carryforward $ 82,000      
v3.26.1
Income Taxes - Schedule of Changes in Total Gross Amount of Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Unrecognized Tax Benefits [Roll Forward]      
Beginning balance $ 39,402 $ 39,737 $ 30,713
Increases related to tax positions taken during the prior period 584 2 7,385
Increases related to tax positions taken during the current period 4,641 4,242 10,131
Decreases related to tax positions taken during the prior period (29) (101) (17)
Lapse of statute of limitations (3,051) (4,478) (8,475)
Ending balance $ 41,547 $ 39,402 $ 39,737
v3.26.1
Income Taxes - Schedule of Refunds Received for Income Taxes (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Income Tax Contingency [Line Items]      
Federal $ 159,500    
Foreign 15,852    
Net cash paid for income taxes 229,965 $ 322,048 $ 134,473
New Jersey      
Income Tax Contingency [Line Items]      
State and local 15,231    
Pennsylvania      
Income Tax Contingency [Line Items]      
State and local 11,701    
Other states and localities      
Income Tax Contingency [Line Items]      
State and local $ 27,681    
v3.26.1
Deferred Revenue, Performance Obligations, and Unbilled Accounts Receivable - (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Disaggregation of Revenue [Line Items]      
Recognition of deferred revenue $ 1,226,000 $ 1,028,000 $ 833,000
Unbilled accounts receivable 50,609 40,761  
Subscription      
Disaggregation of Revenue [Line Items]      
Unbilled accounts receivable $ 11,000 8,000  
Subscription | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-02-01      
Disaggregation of Revenue [Line Items]      
Revenue, remaining performance obligation, recognition period 12 months    
Professional services and other      
Disaggregation of Revenue [Line Items]      
Unbilled accounts receivable $ 40,000 $ 33,000  
v3.26.1
Leases - Additional Information (Details) - USD ($)
$ in Millions
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Leases [Line Items]      
Operating lease expense $ 17 $ 14 $ 16
Maximum      
Leases [Line Items]      
Operating leases, options to extend leases term 5 years    
v3.26.1
Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Leases [Abstract]    
Cash paid for lease liabilities $ 9,545 $ 12,522
Lease right-of-use assets obtained in exchange for new lease liabilities $ 24,023 $ 30,866
v3.26.1
Leases - Schedule of Supplemental Balance Sheet Information Related to Leases (Details)
Jan. 31, 2026
Jan. 31, 2025
Operating Leases    
Weighted average remaining lease term 7 years 9 months 18 days 7 years 8 months 12 days
Weighted average discount rate 4.80% 4.60%
v3.26.1
Leases- Schedule of Maturity of Operating Lease Liabilities (Details)
$ in Thousands
Jan. 31, 2026
USD ($)
Lessee, Operating Lease, Liability, Payment, Due [Abstract]  
2027 $ 14,851
2028 18,538
2029 14,984
2030 14,053
2031 11,293
Thereafter 42,549
Total lease payments 116,268
Less imputed interest (20,409)
Total lease liabilities $ 95,859
v3.26.1
Stockholders' Equity - Additional Information (Details)
$ / shares in Units, $ in Millions
 1 Months Ended 12 Months Ended
Jan. 31, 2026
USD ($)
shares
Jan. 31, 2026
USD ($)
vote
$ / shares
shares
Jan. 31, 2025
USD ($)
$ / shares
shares
Jan. 31, 2024
USD ($)
$ / shares
Aug. 31, 2013
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Common stock, shares outstanding (in shares) 163,778,271 163,778,271 162,583,789    
Options outstanding (in shares) 15,134,876 15,134,876 14,633,921    
Unrecognized compensation cost related to unvested stock options granted | $ $ 417 $ 417      
Weighted-average grant date fair value of options granted (in usd per share) | $ / shares   $ 97.93 $ 80.69 $ 81.17  
Intrinsic value of options exercised | $   $ 120 $ 45 $ 353  
Options granted (in shares)   2,261,282      
Options granted (in usd per share) | $ / shares   $ 216.48      
Authorized repurchase program, amount | $ $ 2,000 $ 2,000      
Share repurchase program term 2 years        
Share repurchases, remaining balance | $ $ 1,820 $ 1,820      
Chief Executive Officer          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Options granted (in shares)     2,650,000    
Options granted (in usd per share) | $ / shares     $ 236.90    
Share based payment award options grant date fair value | $     $ 172    
Common Class A          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vote per common share | vote   1      
2013 Equity Incentive Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Options outstanding (in shares)         0
Number of additional shares authorized (in shares)   13,750,000      
Common stock, shares outstanding, percentage 5.00% 5.00%      
2013 Equity Incentive Plan | Director          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares issued in period (in shares)   6,503,351      
2013 Equity Incentive Plan | Common Class A          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares available for issuance (in shares) 51,279,704 51,279,704      
2013 Employee Stock Purchase Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares available for issuance (in shares) 4,897,856 4,897,856      
Number of additional shares authorized (in shares)   2,200,000      
Common stock, shares outstanding, percentage 1.00% 1.00%      
Number of shares reserved for future issuance (in shares) 4,000,000 4,000,000      
Percent of fair market value paid for shares   85.00%      
Percentage of payroll deductions for shares acquired   15.00%      
2013 Employee Stock Purchase Plan | Director          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of shares issued in period (in shares)   0      
Restricted Stock Units (RSUs)          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Award vesting period   1 year      
Weighted average period of unvested stock (in years)   7 months 6 days      
Weighted-average grant date fair value of options granted (in usd per share) | $ / shares   $ 217.87 $ 213.04 $ 180.78  
Unrecognized compensation cost related to unvested RSUs | $ $ 65 $ 65      
Grant date fair value of RSUs vested | $   $ 253 $ 215 $ 223  
Restricted Stock Units (RSUs) | 2013 Equity Incentive Plan | Minimum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Award vesting period   1 year      
Stock Options          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Award vesting period   4 years      
Weighted average period of unvested stock (in years)   2 years      
Fair value of options vested | $   $ 148 $ 152 $ 114  
Stock Options | 2013 Equity Incentive Plan          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Award vesting period   4 years      
Stock Options | 2013 Equity Incentive Plan | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Options exercisable period   10 years      
Certain Employee Stock Options | 2013 Equity Incentive Plan | Maximum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Award vesting period   7 years      
Certain Employee Stock Options | 2013 Equity Incentive Plan | Minimum          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Award vesting period   5 years      
v3.26.1
Stockholders' Equity - Schedule of Stock Option Activity (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Number of shares    
Options outstanding, beginning balance (in shares) 14,633,921  
Options granted (in shares) 2,261,282  
Options exercised (in shares) (1,374,104)  
Options forfeited/cancelled (in shares) (386,223)  
Options outstanding, ending balance (in shares) 15,134,876 14,633,921
Options vested and exercisable (in shares) 6,558,348  
Options vested and exercisable and expected to vest thereafter (in shares) 15,134,876  
Weighted average exercise price    
Options outstanding, beginning balance (in usd per share) $ 177.65  
Options granted (in usd per share) 216.48  
Options exercised (in usd per share) 184.75  
Options forfeited/cancelled (in usd per share) 209.76  
Options outstanding, ending balance (in usd per share) 181.99 $ 177.65
Options vested and exercisable (in usd per share) 136.89  
Options vested and exercisable and expected to vest thereafter (in usd per share) $ 181.99  
Weighted average remaining contractual term (in years), options outstanding 6 years 3 months 18 days 6 years 9 months 18 days
Weighted average remaining contractual term (in years), options vested and exercisable 3 years 10 months 24 days  
Weighted average remaining contractual term (in years), options vested and exercisable and expected to vest thereafter 6 years 3 months 18 days  
Aggregate intrinsic value (in millions)    
Options outstanding $ 523 $ 860
Options vested and exercisable 496  
Options vested and exercisable and expected to vest thereafter $ 523  
v3.26.1
Stockholders' Equity - Schedule of Weighted-Average Assumptions Used to Estimate Grant Date Fair Value of Options Granted (Details) - Stock Options
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Volatility, minimum 39.00% 39.00% 39.00%
Volatility, maximum 40.00% 41.00% 41.00%
Risk-free interest rate, Minimum 3.68% 3.46% 3.34%
Risk-free interest rate, Maximum 4.41% 4.65% 4.73%
Dividend yield 0.00% 0.00% 0.00%
Chief Executive Officer      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Volatility, minimum   39.00%  
Expected term (in years)   7 years 7 months 6 days  
Risk-free interest rate, Minimum   4.18%  
Dividend yield   0.00%  
Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected term (in years) 6 years 3 months 18 days 5 years 6 months 6 years 3 months 18 days
Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected term (in years) 7 years 7 years 7 months 6 days 7 years
v3.26.1
Stockholders' Equity - Schedule of Restricted Stock Unit (RSU) Activity (Details) - Restricted Stock Units (RSUs)
 12 Months Ended
Jan. 31, 2026
$ / shares
shares
Unreleased restricted stock units  
Beginning balance (in shares) | shares 880,026
RSUs granted (in shares) | shares 1,065,116
RSUs vested (in shares) | shares (988,578)
RSUs forfeited/cancelled (in shares) | shares (66,508)
Ending balance (in shares) | shares 890,056
Weighted  average grant date fair value  
Beginning balance (in usd per share) | $ / shares $ 206.25
RSUs granted (in usd per share) | $ / shares 217.87
RSUs vested (in usd per share) | $ / shares 213.67
RSUs forfeited/cancelled (in usd per share) | $ / shares 212.68
Ending balance (in usd per share) | $ / shares $ 211.42
v3.26.1
Stockholders' Equity - Schedule of Repurchase Programs (Details)
$ / shares in Units, $ in Thousands
 12 Months Ended
Jan. 31, 2026
USD ($)
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Total number of shares repurchased (in shares) | shares 801,735
Average price paid per share (in usd per share) | $ / shares $ 224.43
Amount repurchased | $ $ 179,930
v3.26.1
Other Income (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Other Income and Expenses [Abstract]      
Foreign currency gain (loss) $ 1,535 $ (3,274) $ 124
Accretion on investments 8,451 22,622 24,817
Interest income, net 267,219 207,987 133,748
Miscellaneous income 934 611 0
Other income, net $ 278,139 $ 227,946 $ 158,689
v3.26.1
Net Income per Share - Schedule of Numerators and Denominators of the Basic and Diluted EPS Computations for Common Stock (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Numerator:      
Net income, basic $ 908,906 $ 714,138  
Reallocation as a result of conversion of Class B to Class A common stock:      
Net income, basic 0 0  
Reallocation of net income to Class B common stock 0 0  
Net income, diluted $ 908,906 $ 714,138  
Denominator:      
Weighted average common shares outstanding, basic (in shares) 163,667 161,879 160,532
Conversion of Class B to Class A common stock (in shares) 0 0  
Effect of potentially dilutive common shares (in shares) 3,328 3,353  
Weighted average common shares outstanding, diluted (in shares) 166,995 165,232 163,486
Net income per share:      
Basic (in usd per share) $ 5.55 $ 4.41 $ 3.27
Diluted (in usd per share) $ 5.44 $ 4.32 $ 3.22
Common Class A      
Numerator:      
Net income, basic     $ 491,747
Reallocation as a result of conversion of Class B to Class A common stock:      
Net income, basic     33,958
Reallocation of net income to Class B common stock     0
Net income, diluted     $ 525,705
Denominator:      
Weighted average common shares outstanding, basic (in shares)     150,162
Conversion of Class B to Class A common stock (in shares)     10,370
Effect of potentially dilutive common shares (in shares)     2,954
Weighted average common shares outstanding, diluted (in shares)     163,486
Net income per share:      
Basic (in usd per share)     $ 3.27
Diluted (in usd per share)     $ 3.22
Class B common stock      
Numerator:      
Net income, basic     $ 33,958
Reallocation as a result of conversion of Class B to Class A common stock:      
Net income, basic     0
Reallocation of net income to Class B common stock     8,887
Net income, diluted     $ 42,845
Denominator:      
Weighted average common shares outstanding, basic (in shares)     10,370
Conversion of Class B to Class A common stock (in shares)     0
Effect of potentially dilutive common shares (in shares)     2,954
Weighted average common shares outstanding, diluted (in shares)     13,324
Net income per share:      
Basic (in usd per share)     $ 3.27
Diluted (in usd per share)     $ 3.22
v3.26.1
Net Income per Share - Schedule of Potential Common Share Equivalents Excluded where the Inclusion would be Anti-dilutive (Details) - shares
shares in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Earnings Per Share [Abstract]      
Options and RSUs (in shares) 9,549 8,609 6,083
v3.26.1
Commitment and Contingencies (Details)
$ in Millions
Aug. 13, 2025
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Loss contingency accrual $ 31
v3.26.1
Segment Information - Narrative (Details)
 12 Months Ended
Jan. 31, 2026
segment
Segment Reporting [Abstract]  
Number of operating segments 1
Number of reportable segments 1
v3.26.1
Segment Reporting - Schedule of Segment Reporting Information, by Segment (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Revenues from External Customers and Long-Lived Assets [Line Items]      
Total revenues $ 3,195,311 $ 2,746,619 $ 2,363,673
Total cost of revenues [1] 782,019 699,636 677,291
Research and development [1] 767,386 693,078 629,031
Sales and marketing [1] 428,798 396,726 381,472
General and administrative [1] 300,739 265,744 246,545
Other income, net 278,139 227,946 158,689
Income tax provision 285,602 205,243 62,318
Net income 908,906 714,138 525,705
Subscription      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Total revenues 2,684,194 2,284,659 1,901,593
Total cost of revenues [1] 362,888 323,070 290,577
Professional services and other      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Total revenues 511,117 461,960 462,080
Total cost of revenues [1] 419,131 376,566 386,714
Reportable Segment      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Total revenues 3,195,311 2,746,619 2,363,673
Research and development 562,493 507,092 456,041
Sales and marketing 321,061 293,105 276,505
General and administrative 164,375 157,271 176,048
Operating income - adjusted 1,433,845 1,152,343 842,526
Other segment items 517,476 460,908 413,192
Other income, net 278,139 227,946 158,689
Income tax provision 285,602 205,243 62,318
Net income 908,906 714,138 525,705
Reportable Segment | Subscription      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Total cost of revenues 352,202 312,169 279,626
Reportable Segment | Professional services and other      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Total cost of revenues $ 361,335 $ 324,639 $ 332,927
[1]
(1) Includes stock-based compensation as follows:
Cost of subscription$7,342 $6,591 $6,483 
Cost of professional services and other57,376 51,377 53,237 
Research and development204,893 185,901 172,876 
Sales and marketing97,355 90,178 90,865 
General and administrative105,737 103,303 70,272 
Total stock-based compensation$472,703 $437,350 $393,733 
v3.26.1
Information about Geographic Areas and Products - Revenue by Geographic Area (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Disaggregation of Revenue [Line Items]      
Total revenues $ 3,195,311 $ 2,746,619 $ 2,363,673
North America      
Disaggregation of Revenue [Line Items]      
Total revenues 1,903,342 1,621,697 1,387,425
Europe      
Disaggregation of Revenue [Line Items]      
Total revenues 939,630 790,777 662,560
Asia Pacific      
Disaggregation of Revenue [Line Items]      
Total revenues 280,162 265,735 250,600
Other international      
Disaggregation of Revenue [Line Items]      
Total revenues $ 72,177 $ 68,410 $ 63,088
v3.26.1
Information about Geographic Areas and Products - Schedule of Long-Lived Assets by Geography (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Jan. 31, 2025
Disaggregation of Revenue [Line Items]    
Total long-lived assets $ 70,261 $ 55,912
North America    
Disaggregation of Revenue [Line Items]    
Total long-lived assets 54,089 47,144
Europe    
Disaggregation of Revenue [Line Items]    
Total long-lived assets 11,018 6,778
Asia Pacific    
Disaggregation of Revenue [Line Items]    
Total long-lived assets 4,239 1,295
Other international    
Disaggregation of Revenue [Line Items]    
Total long-lived assets $ 915 $ 695
v3.26.1
Information about Geographic Areas and Products - Schedule of Total Revenues (Details)
$ in Thousands
 12 Months Ended
Jan. 31, 2026
USD ($)
product_area
Jan. 31, 2025
USD ($)
Jan. 31, 2024
USD ($)
Disaggregation of Revenue [Line Items]      
Number of product areas | product_area 2    
Total revenues $ 3,195,311 $ 2,746,619 $ 2,363,673
Total subscription      
Disaggregation of Revenue [Line Items]      
Total revenues 2,684,194 2,284,659 1,901,593
Commercial Solutions      
Disaggregation of Revenue [Line Items]      
Total revenues 1,257,568 1,104,888 995,803
R&D and Quality Solutions      
Disaggregation of Revenue [Line Items]      
Total revenues 1,426,626 1,179,771 905,790
Total professional services and other      
Disaggregation of Revenue [Line Items]      
Total revenues 511,117 461,960 462,080
Commercial Solutions      
Disaggregation of Revenue [Line Items]      
Total revenues 189,307 185,302 185,981
R&D and Quality Solutions      
Disaggregation of Revenue [Line Items]      
Total revenues $ 321,810 $ 276,658 $ 276,099
v3.26.1
401(k) Plan (Details) - USD ($)
 12 Months Ended
Jan. 01, 2025
Jan. 31, 2026
Jan. 31, 2025
Jan. 31, 2024
Defined Contribution Plan Disclosure [Line Items]        
Total expense related defined benefit plan   $ 18,000,000 $ 10,000,000 $ 9,000,000
401(k) Plan        
Defined Contribution Plan Disclosure [Line Items]        
Employer maximum matching contribution amount per employee per year $ 4,000      
RRSP | CANADA        
Defined Contribution Plan Disclosure [Line Items]        
Employer maximum matching contribution amount per employee per year   $ 2,000    
v3.26.1
Subsequent Events (Details)
$ in Millions
Mar. 10, 2026
USD ($)
Rise Healthcare Tech, Inc. (Ostro) | Subsequent Event  
Subsequent Event [Line Items]  
Payments to acquire businesses, gross $ 100